https://www.lmi.no/2024/08/19/bayer-vinner-ankesak-i-usa/ 2024-08-19T12:45:35+00:00 https://www.lmi.no/2024/08/19/who-har-erklaert-internasjonal-folkehelsekrise-et-lite-dansk-selskap-har-verdens-eneste-vaksine/ 2024-08-19T12:46:35+00:00 https://www.lmi.no/2024/08/19/sendte-gjentatte-varsler-frykter-pasienten-skal-do/ 2024-08-19T12:47:41+00:00 https://www.lmi.no/2024/08/19/nye-migrenemedisiner-%e2%81%a0-revolusjonerende-for-kvinner/ 2024-08-19T12:48:32+00:00 https://www.lmi.no/2024/08/19/vaksineaksjer-steg-kraftig-pa-grunn-av-mpox-helsekrisen/ 2024-08-19T12:50:07+00:00 https://www.lmi.no/2024/08/20/ap-og-hoyre-en-handlingsplan-for-helsedata-er-fornuftig/ 2024-08-20T08:39:36+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Troen-Roed-Skymoen-Sandset-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Troen-Roed-Skymoen-Sandset-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Roed-og-Troen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_-Hege-Edvardsen-og-Helge-Rosjo-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Helge-Rosjo-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Susanne-Lie_Datatilsynet-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Ingrid-Stenstadvold-Ross-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Sandset-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Ishita-Barua-scaled.jpg https://www.lmi.no/2024/08/20/helsesatsingen-trenger-fart-og-kraft/ 2024-08-20T08:45:27+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-22-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-22-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-16-scaled.jpg https://www.lmi.no/2024/08/20/arendaluka-i-bilder/ 2024-08-20T08:54:12+00:00 https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-67-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-67-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-23-1-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-20-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-37-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-57-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-18-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-46-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-47-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-48-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-16-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-22-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-20-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-32-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-18-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-32-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-18-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-21-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Helsedata-14-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-17-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-12-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-10-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-25-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-32-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-41-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-10-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-15-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-42-scaled.jpg https://www.lmi.no/2024/08/20/vestre-om-refusjon-pa-migrenemedisin-dmp-vurderer-fortsatt-saken/ 2024-08-20T09:14:36+00:00 https://www.lmi.no/2024/08/20/oslo-hoyre-krever-fortgang-for-ny-innovasjonspark/ 2024-08-20T09:15:41+00:00 https://www.lmi.no/2024/08/20/helseregistrene-dataene-er-der-slik-far-vi-brukt-dem/ 2024-08-20T09:16:59+00:00 https://www.lmi.no/2024/08/20/hva-er-egentlig-helsedata-se-video/ 2024-08-20T09:17:27+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Skjermbilde-helsedatavideo.png https://www.lmi.no/2024/08/20/a-handtere-legemiddelmangel-er-helsehjelp/ 2024-08-20T09:18:09+00:00 https://www.lmi.no/2024/08/20/kognitiv-screening-en-forutsetning-at-pasienten-onsker-a-vite/ 2024-08-20T09:19:03+00:00 https://www.lmi.no/2024/08/20/ms-forskerne-apner-for-fremtidig-kur-men-det-blir-langt-frem-i-tid/ 2024-08-20T09:19:59+00:00 https://www.lmi.no/2024/08/20/skummel-variant-sprer-seg-grunn-til-a-vaere-bekymret/ 2024-08-20T09:20:58+00:00 https://www.lmi.no/2024/08/20/tilbakeslag-for-pfizer-og-biontechs-kombinerte-covid-og-influensavaksine/ 2024-08-20T09:21:52+00:00 https://www.lmi.no/2024/08/20/bergenbio-inngar-samarbeid-med-amerikansk-teknologiselskap/ 2024-08-20T09:23:13+00:00 https://www.lmi.no/2024/08/21/byradet-og-oslo-science-hub-enige-om-tomtesalg/ 2024-08-21T07:45:13+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Signering_radhuset_august_2024-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Signering_radhuset_august_2024-scaled.jpg https://www.lmi.no/2024/08/21/kommunal-tomt-kan-redde-kreftforskning/ 2024-08-21T07:55:38+00:00 https://www.lmi.no/2024/08/21/ett-skritt-naermere-eiendomskjop-for-oslo-science-hub/ 2024-08-21T07:56:36+00:00 https://www.lmi.no/2024/08/21/lundbeck-kan-vise-til-hoyeste-halvarsomsetning-i-selskapets-historie/ 2024-08-21T07:58:26+00:00 https://www.lmi.no/2024/08/21/skuffende-resultater-for-medisin-mot-mpox-i-ny-studie/ 2024-08-21T07:59:23+00:00 https://www.lmi.no/2024/08/21/leukemi-studier-har-spart-nordiske-land-for-655-millioner-kroner/ 2024-08-21T08:00:20+00:00 https://www.lmi.no/2024/08/21/nykode-therapeutics-avbryter-studie/ 2024-08-21T08:01:16+00:00 https://www.lmi.no/2024/08/22/nho-geneo-inviterer-til-medlemsmote-om-ventetidsloftet/ 2024-08-22T10:27:47+00:00 https://www.lmi.no/wp-content/uploads/2024/08/ventetidsloftet-forste-mote-kopi-1.jpg https://www.lmi.no/wp-content/uploads/2024/08/ventetidsloftet-forste-mote-kopi-1.jpg https://www.lmi.no/2024/08/22/nykode-sjefen-innrommer-avbrytelse-av-studie-er-et-tilbakeslag/ 2024-08-22T10:42:47+00:00 https://www.lmi.no/2024/08/22/ny-slankemedisin-pa-vei-til-norge-dette-betyr-det-for-prisen/ 2024-08-22T10:44:00+00:00 https://www.lmi.no/2024/08/22/bergenbio-melder-om-stabil-kontantbruk/ 2024-08-22T10:45:04+00:00 https://www.lmi.no/2024/08/22/frankrike-skal-donere-100-000-vaksiner-mot-m-pox/ 2024-08-22T10:46:01+00:00 https://www.lmi.no/2024/08/22/lundbeck-ser-blockbusterpotensiale-i-egen-migrenemedisin/ 2024-08-22T10:46:55+00:00 https://www.lmi.no/2024/08/23/disse-vil-bli-direktor-i-dmp/ 2024-08-23T12:23:45+00:00 https://www.lmi.no/2024/08/23/abelia-direktor-oystein-eriksen-soreide-slik-forandrer-vi-norges-sardinboks-okonomi/ 2024-08-23T12:24:50+00:00 https://www.lmi.no/2024/08/23/alzheimer-medisin-godkjent-i-storbritannia-avslatt-i-europa/ 2024-08-23T12:26:02+00:00 https://www.lmi.no/2024/08/23/gentest-kan-spare-brystkreft-pasienter-for-unodvendig-kjemoterapi-mandag-blir-det-ja-eller-nei-i-beslutningsforum/ 2024-08-23T12:27:21+00:00 https://www.lmi.no/2024/08/23/helsegevinster-pa-billigsalg/ 2024-08-23T12:28:31+00:00 https://www.lmi.no/2024/08/23/regulatorisk-hostmote-2024-2/ 2024-08-23T12:56:06+00:00 https://www.lmi.no/wp-content/uploads/2024/08/REG-hostmote-2024-Arrangement-bilde.jpg https://www.lmi.no/wp-content/uploads/2024/08/REG-hostmote-2024-Arrangement-bilde.jpg https://www.lmi.no/2024/08/26/roche-norge-sjefen-mener-det-er-godt-lederskap-a-si-unnskyld/ 2024-08-26T08:46:59+00:00 https://www.lmi.no/2024/08/26/hod-gir-novo-nordisk-medhold-i-klagesak-dmp-ma-betale/ 2024-08-26T08:48:46+00:00 https://www.lmi.no/2024/08/26/rekordkvartal-for-vistin-pharma/ 2024-08-26T08:49:41+00:00 https://www.lmi.no/2024/08/26/viktig-nyrekreftvedtak-pa-mandag-har-potensial-til-a-kurere/ 2024-08-26T08:50:41+00:00 https://www.lmi.no/2024/08/26/disse-metodene-skal-beslutningsforum-ta-stilling-til-i-sitt-forste-mote-etter-sommeren/ 2024-08-26T08:52:28+00:00 https://www.lmi.no/2024/08/26/amanda-30-hadde-tre-maneder-igjen-a-leve-sa-snudde-alt/ 2024-08-26T08:53:45+00:00 https://www.lmi.no/2024/08/26/overlege-om-ny-unntaksordning-det-loser-langt-fra-hele-problemet/ 2024-08-26T08:55:09+00:00 https://www.lmi.no/2024/08/26/novo-nordisks-diabetesmedisin-kan-bli-en-del-av-neste-runde-med-prisforhandlinger-i-usa/ 2024-08-26T08:56:09+00:00 https://www.lmi.no/2024/08/27/opplever-okt-interesse-for-naeringslivet-har-rekruttert-over-100-studenter-til-helseindustrien/ 2024-08-27T08:32:15+00:00 https://www.lmi.no/2024/08/27/siemens-healthineers-kjoper-novartis-virksomhet/ 2024-08-27T08:34:38+00:00 https://www.lmi.no/2024/08/27/astrazeneca-utvider-legemiddelfabrikk-investerer-15-milliarder-kroner/ 2024-08-27T08:35:37+00:00 https://www.lmi.no/2024/08/27/ja-til-medisin-mot-benmargskreft-en-av-de-store-vi-har-manglet/ 2024-08-27T08:36:49+00:00 https://www.lmi.no/2024/08/27/beslutningsforum-gir-tommel-opp-for-brystkrefttest-fem-behandlinger-far-nei/ 2024-08-27T08:37:50+00:00 https://www.lmi.no/2024/08/27/beslutningsforum-godkjenner-praksisendrende-immunterapi-til-nyrekreftopererte/ 2024-08-27T08:43:12+00:00 https://www.lmi.no/2024/08/27/mener-det-bor-opprettes-en-interregional-vurderingskomite-for-unntaksordningen/ 2024-08-27T08:44:27+00:00 https://www.lmi.no/2024/08/27/meld-deg-pa-farmasidagene-2024/ 2024-08-27T08:45:29+00:00 https://www.lmi.no/wp-content/uploads/2024/08/a_Velkommen2024-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Et-utvalg-av-arets-deltakere-i-programmet-1.png https://www.lmi.no/2024/08/28/ozempic-rasjonering-i-apotek-har-mer-enn-halvert-omsetningen/ 2024-08-28T09:26:59+00:00 https://www.lmi.no/2024/08/28/demensforsker-en-medisinsk-skandale/ 2024-08-28T09:27:59+00:00 https://www.lmi.no/2024/08/28/lmi-hoydepunkter-fra-arendalsuka-2024/ 2024-08-28T09:28:32+00:00 https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-67-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-56-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Veikart_helseindustri-22-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Helsedata_Barua-Troen-Roed-Skymoen-Sandset-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI_Sosialsamling_Arendalsuka2024-41-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Voksenvaksinasjonsprogram-12-scaled.jpg https://www.lmi.no/2024/08/28/eli-lilly-selger-hetteglass-med-fedmemiddel-til-halv-pris/ 2024-08-28T09:29:45+00:00 https://www.lmi.no/2024/08/28/medisinforbruk-kan-forutsi-utvikling-av-tidlig-alzheimers/ 2024-08-28T09:30:59+00:00 https://www.lmi.no/2024/08/28/kjent-middel-for-fodende-kvinner-kan-ha-overraskende-effekt-mot-alzheimer/ 2024-08-28T09:32:33+00:00 https://www.lmi.no/2024/08/28/jj-far-utvidet-eu-godkjenning-for-lungekreftmedisinen-til-danske-genmab/ 2024-08-28T09:33:36+00:00 https://www.lmi.no/2024/08/29/pci-biotech-skal-oke-produksjonen-av-eksperimentell-genterapi-teknologi/ 2024-08-29T07:37:47+00:00 https://www.lmi.no/2024/08/29/sender-sjokkbolger-gjennom-skandinavia-en-medisinsk-skandale/ 2024-08-29T07:38:53+00:00 https://www.lmi.no/2024/08/29/bioarctic-satser-videre-med-parkinson-kandidat/ 2024-08-29T07:40:13+00:00 https://www.lmi.no/2024/08/29/oncoinvent-direktoren-slutter-oystein-soug-blir-ny-direktor/ 2024-08-29T07:41:59+00:00 https://www.lmi.no/2024/08/28/partnerskapet-for-sjeldne-sykdommer-lansert/ 2024-08-29T10:29:49+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Barnetsbeste_Sjeldnediagnoser-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Barnetsbeste_Sjeldnediagnoser-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Partnerskapet-for-sjeldne-sykdommer_panel.png https://www.lmi.no/2024/08/30/feirer-50-ar-med-kontrastvaeske-fabrikk-i-lindesnes/ 2024-08-30T08:51:24+00:00 https://www.lmi.no/2024/08/30/nho-geneo-dette-utfordrer-hele-den-norske-velferdsmodellen/ 2024-08-30T08:53:37+00:00 https://www.lmi.no/2024/08/30/circio-sikter-mot-sitt-forste-strategiske-partnerskap-i-2025/ 2024-08-30T08:57:49+00:00 https://www.lmi.no/2024/08/30/arctic-bioscience-naermer-seg-avgjorende-milepael-vi-beveger-oss-mot-kommersialisering-av-en-blockbuster/ 2024-08-30T08:59:26+00:00 https://www.lmi.no/2024/08/30/nytt-norsk-islandsk-samarbeid-om-hiv-medisinar-og-biologiske-legemiddel/ 2024-08-30T09:00:55+00:00 https://www.lmi.no/2024/08/30/lytix-jobber-tett-med-amerikansk-partner-etter-lovende-studiedata/ 2024-08-30T09:02:04+00:00 https://www.lmi.no/2024/08/30/det-skal-veldig-mye-til-for-at-investorene-skal-kaste-penger-etter-det-selskapet/ 2024-08-30T09:05:37+00:00 https://www.lmi.no/2024/08/30/gir-102-millioner-kroner-til-doktorgrader-i-naeringslivet-flere-helseselskaper-far-stotte/ 2024-08-30T09:07:21+00:00 https://www.lmi.no/2024/08/30/legemiddelselskapene-gjemmer-enorme-overskudd-i-skatteparadis/ 2024-08-30T09:12:53+00:00 https://www.lmi.no/2024/08/29/ny-administrerende-direktor-i-bayer/ 2024-08-30T09:16:23+00:00 https://www.lmi.no/wp-content/uploads/2024/08/erik-helstad-jpg.webp https://www.lmi.no/wp-content/uploads/2024/08/erik-helstad-jpg.webp https://www.lmi.no/2024/09/02/legemiddelverket-med-endret-rad-okt-risiko-for-alvorlige-bivirkninger/ 2024-09-02T08:00:01+00:00 https://www.lmi.no/2024/09/02/eu-godkjenning-av-medisin-mot-hoyt-blodtrykk-i-lungene/ 2024-09-02T08:01:16+00:00 https://www.lmi.no/2024/09/02/studie-pa-seponering-av-betablokkere-viktig-informasjon-men-ikke-mulig-a-konkludere/ 2024-09-02T08:04:12+00:00 https://www.lmi.no/2024/09/02/ketaminbehandling-sa-langt-ikke-mistet-en-eneste-pasient-i-selvmord/ 2024-09-02T08:06:15+00:00 https://www.lmi.no/2024/09/02/msd-avbryter-to-keytruda-studier/ 2024-09-02T08:07:43+00:00 https://www.lmi.no/2024/09/02/slik-jobber-ge-healthcare-med-a-avdekke-menneskerettighetsbrudd/ 2024-09-02T08:11:35+00:00 https://www.lmi.no/2024/09/02/tre-selskaper-i-usa-har-gatt-med-pa-a-betale-300-millioner-dollar-i-et-forlik-for-medvirkning-til-opioidkrisen/ 2024-09-02T08:13:04+00:00 https://www.lmi.no/2024/09/02/har-sammenlignet-immunterapier-ved-hjelp-av-norske-helseregisterdata/ 2024-09-02T10:15:50+00:00 https://www.lmi.no/2024/09/03/husk-a-melde-deg-pa-frokostseminar-om-helsedata/ 2024-09-03T07:22:10+00:00 https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/wp-content/uploads/2024/09/Guri-Rortveit_FHI.webp https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/2024/09/03/kan-alzheimers-sykdom-diagnostiseres-med-en-blodprove/ 2024-09-03T10:08:05+00:00 https://www.lmi.no/2024/09/03/legemiddel-mot-sjelden-lungesykdom-godkjent-i-europa/ 2024-09-03T10:09:58+00:00 https://www.lmi.no/2024/09/03/oppfattet-immunterapi-kombo-mot-spiserorskreft-som-uaktuell-a-innfore/ 2024-09-03T10:24:39+00:00 https://www.lmi.no/2024/09/03/vi-bruker-allergimedisiner-for-en-milliard-kroner/ 2024-09-03T10:26:11+00:00 https://www.lmi.no/2024/09/03/eu-godkjenning-til-ny-kombinasjonsbehandling-av-blaerekreft/ 2024-09-03T10:27:15+00:00 https://www.lmi.no/2024/09/03/novo-nordisk-offentliggjor-post-hoc-kardiovaskulaere-data-for-semaglutid/ 2024-09-03T10:28:22+00:00 https://www.lmi.no/2024/09/03/ny-bayer-sjef-har-vel-en-litt-annen-vei-inn-i-legemiddelindustrien-enn-de-fleste/ 2024-09-03T10:29:41+00:00 https://www.lmi.no/2024/09/03/novo-nordisk-forventer-periodisk-mangel-av-ozempic-ved-utgangen-av-aret/ 2024-09-03T10:30:41+00:00 https://www.lmi.no/2024/09/04/forste-dialogarena-etter-veikartet/ 2024-09-04T11:27:22+00:00 https://www.lmi.no/wp-content/uploads/2024/09/IMG_1929-scaled-e1725430607540.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_1929-scaled-e1725430607540.jpg https://www.lmi.no/2024/09/05/disse-skal-sorge-for-at-norge-lykkes-med-eksportsatsingen/ 2024-09-05T08:55:03+00:00 https://www.lmi.no/2024/09/05/studiestopp-tvinger-nykode-til-omfattende-nedbemanning/ 2024-09-05T08:57:01+00:00 https://www.lmi.no/2024/09/05/skandinavisk-studie-finner-ingen-sammenheng-mellom-glp-1-legemidler-og-selvmord/ 2024-09-05T08:58:45+00:00 https://www.lmi.no/2024/09/05/ny-metode-vil-forbedre-vaksineteknologien-mrna/ 2024-09-05T09:00:42+00:00 https://www.lmi.no/2024/09/05/ny-og-lovende-behandling-mot-myelomatose/ 2024-09-05T09:01:48+00:00 https://www.lmi.no/2024/09/05/vitalthings-har-fatt-europeisk-godkjennelse-for-pasientmonitor/ 2024-09-05T09:02:49+00:00 https://www.lmi.no/2024/09/05/presenterte-preklinisk-pluvia-kandidat-ser-frem-til-a-ga-i-klinikk/ 2024-09-05T09:03:37+00:00 https://www.lmi.no/2024/09/05/blaerekreft-medisin-som-dobler-overlevelsen-er-na-eu-godkjent/ 2024-09-05T09:04:30+00:00 https://www.lmi.no/2024/09/09/store-forskjeller-i-tilgang-pa-nye-legemidler-i-europa/ 2024-09-09T08:55:14+00:00 https://www.lmi.no/2024/09/09/den-svenske-regjeringen-lover-milliardsatsing-pa-forskning-og-innovasjon/ 2024-09-09T08:57:13+00:00 https://www.lmi.no/2024/09/09/starter-fase-tre-av-norsk-studie-pa-narkolepsi-medisin/ 2024-09-09T09:17:19+00:00 https://www.lmi.no/2024/09/09/usa-skal-stemme-over-lovforslag-som-toyler-kinesiske-helseselskap-sikkerhetsradgiver-mener-norge-tjener-pa-a-folge-etter/ 2024-09-09T09:18:50+00:00 https://www.lmi.no/2024/09/09/astrazeneca-ansatte-arrestert-i-kina/ 2024-09-09T09:20:10+00:00 https://www.lmi.no/2024/09/09/sandoz-lanserer-en-kopi-av-semaglutid-i-canada-i-2026/ 2024-09-09T09:21:46+00:00 https://www.lmi.no/2024/09/09/gar-sammen-i-partnerskap-for-sjeldne-sykdommer/ 2024-09-09T09:23:22+00:00 https://www.lmi.no/2024/09/09/bavarian-nordics-koppevaksine-slatt-av-modernas-vaksine-i-tidlig-dyrestudie/ 2024-09-09T09:24:26+00:00 https://www.lmi.no/2024/09/09/ny-medisin-virker-godt-mot-plager-i-overgangsalderen/ 2024-09-09T09:26:04+00:00 https://www.lmi.no/2024/09/09/barne-og-ungdomspsykiater-om-adhd-%e2%81%a0-medisineringen-har-sklidd-ut/ 2024-09-09T10:09:23+00:00 https://www.lmi.no/2024/09/09/fortsatt-hoyest-medisinpriser-i-usa/ 2024-09-09T10:10:56+00:00 https://www.lmi.no/2024/09/09/flere-tilfeller-av-antibiotikaresistente-bakterier-pavist-pa-ous/ 2024-09-09T10:16:06+00:00 https://www.lmi.no/2024/09/09/ny-podcast-na-er-nykode-prisgitt-sine-partnere/ 2024-09-09T10:18:47+00:00 https://www.lmi.no/2024/09/09/plutselig-tar-den-nye-bayer-sjefen-frem-fotballen-for-a-trikse-man-ma-ha-mer-action-og-brak-pa-kontoret/ 2024-09-09T10:19:51+00:00 https://www.lmi.no/2024/09/09/helt-vanlig-kjokkeningrediens-kan-utlose-sklerose/ 2024-09-09T10:23:46+00:00 https://www.lmi.no/2024/09/09/lundbeck-tester-sin-mest-lovende-migrenekandidat-i-kombinasjon-med-abbvie-produkt/ 2024-09-09T10:25:17+00:00 https://www.lmi.no/2024/09/09/dette-oker-risikoen-for-at-eldre-far-alzheimers/ 2024-09-09T10:27:50+00:00 https://www.lmi.no/2024/09/09/klar-beskjed-til-over-halv-million-nordmenn-like-viktig-som-livreddende-forstehjelp/ 2024-09-09T10:32:58+00:00 https://www.lmi.no/2024/09/09/innspill-til-ny-stortingsmelding-om-industri/ 2024-09-09T11:53:32+00:00 https://www.lmi.no/wp-content/uploads/2023/12/NP-1.jpg https://www.lmi.no/wp-content/uploads/2023/12/NP-8.jpg https://www.lmi.no/2024/09/10/astrazeneca-melder-om-positive-resultater-i-lungekreftstudie/ 2024-09-10T07:04:10+00:00 https://www.lmi.no/2024/09/10/to-organisasjoner-kjemper-na-for-fokus-pa-sjeldne-sykdommer/ 2024-09-10T07:06:55+00:00 https://www.lmi.no/2024/09/10/amerikansk-og-kinesisk-bioteknologi-slar-keytruda-i-direkte-sammenligning/ 2024-09-10T07:08:34+00:00 https://www.lmi.no/2024/09/10/norsk-ki-forskning-kan-gi-demensgjennombrudd-men-vi-ma-handle-na/ 2024-09-10T07:12:15+00:00 https://www.lmi.no/2024/09/10/ozempic-salget-daler-etter-regelendring/ 2024-09-10T07:15:19+00:00 https://www.lmi.no/2024/09/10/det-amerikanske-underhuset-vedtok-lovgivning-mot-kinesisk-biotek-samarbeid/ 2024-09-10T07:16:31+00:00 https://www.lmi.no/2024/09/11/helsedata-pa-agendaen/ 2024-09-11T09:38:20+00:00 https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/2024/09/10/laer-om-kliniske-studier-under-forskningsdagene/ 2024-09-11T10:40:44+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Eline-og-Aslaug-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Eline-og-Aslaug-scaled.jpg https://www.lmi.no/2024/09/11/dette-lover-hoyre-helsenaeringen-i-neste-valgperiode/ 2024-09-11T10:58:51+00:00 https://www.lmi.no/2024/09/11/adhd-studie-viser-at-ungdom-onsker-stotte-i-daglige-rutiner-og-paminnelser-om-a-ta-medisiner/ 2024-09-11T10:59:53+00:00 https://www.lmi.no/2024/09/11/apner-doren-for-ikke-godkjente-legemidler-etter-sammenbrudd-i-prisforhandling/ 2024-09-11T11:01:28+00:00 https://www.lmi.no/2024/09/11/gsk-stenger-produksjonsanlegget-i-storbritannia/ 2024-09-11T11:02:38+00:00 https://www.lmi.no/2024/09/13/bekymret-for-anbud-det-blir-mindre-aktuelt-a-legge-kliniske-studier-til-norge/ 2024-09-13T07:58:10+00:00 https://www.lmi.no/2024/09/13/han-er-sitert-over-80-000-ganger-slik-tror-han-vi-vil-behandle-kreft-i-fremtiden/ 2024-09-13T08:00:52+00:00 https://www.lmi.no/2024/09/13/gsk-stopper-utviklingen-av-herpesvaksine-etter-klinisk-nederlag/ 2024-09-13T08:01:48+00:00 https://www.lmi.no/2024/09/13/sterke-reaksjoner-pa-anbud-med-ikke-godkjente-medisiner-fokuset-er-kun-pa-lavest-mulig-pris/ 2024-09-13T08:03:36+00:00 https://www.lmi.no/2024/09/13/kreft-endringer-hos-nykode-partner-genentech-ble-gjort-av-vitenskapelige-hensyn/ 2024-09-13T08:04:43+00:00 https://www.lmi.no/2024/09/13/novo-nordisk-rapporterer-om-typisk-bivirkningsprofil-for-nytt-vekttapshap/ 2024-09-13T08:05:49+00:00 https://www.lmi.no/2024/09/13/danske-abacus-medicine-skal-lansere-legemiddel-mot-sjeldne-leversykdommer-i-norden/ 2024-09-13T08:06:57+00:00 https://www.lmi.no/2024/09/13/navamedic-signerer-avtale-med-svensk-e-helseselskap-lager-app-for-parkinson-behandling/ 2024-09-13T08:08:52+00:00 https://www.lmi.no/2024/09/13/globalt-svindelnettverk-skal-sta-bak-falsk-ozempic/ 2024-09-13T08:09:44+00:00 https://www.lmi.no/2024/09/13/har-funnet-opp-teknologi-for-a-teste-kvaliteten-pa-mrna-skal-lage-selskap/ 2024-09-13T08:11:16+00:00 https://www.lmi.no/2024/09/13/millioninvesteringer-fra-danske-legemiddelfond-til-ny-talentfabrikk/ 2024-09-13T08:12:27+00:00 https://www.lmi.no/2024/09/13/novo-nordisks-nye-slankepille-gir-betydelig-vekttap-i-tidlig-studie/ 2024-09-13T08:13:19+00:00 https://www.lmi.no/2024/09/13/horing-om-endring-i-legemiddelforskriften/ 2024-09-13T08:44:15+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/09/16/forskere-avslorer-kreftcellenes-hemmelige-gjemmested/ 2024-09-16T07:02:45+00:00 https://www.lmi.no/2024/09/16/malrettet-cellegift-er-effektiv-mot-hjernemetastaser-hos-brystkreftpasienter-dette-blir-na-forstevalget/ 2024-09-16T07:13:26+00:00 https://www.lmi.no/2024/09/16/lovende-data-presentert-for-her2-brystkreftpasienter-svaert-opploftende/ 2024-09-16T07:17:03+00:00 https://www.lmi.no/2024/09/16/cytovation-har-fatt-orphan-drug-status-i-usa/ 2024-09-16T07:18:36+00:00 https://www.lmi.no/2024/09/16/immunterapi-professor-hedret-for-banebrytende-arbeid/ 2024-09-16T07:19:37+00:00 https://www.lmi.no/2024/09/16/exact-therapeutics-retter-alle-ressurser-inn-mot-fase-2-studie/ 2024-09-16T07:21:21+00:00 https://www.lmi.no/2024/09/16/billig-eller-kjempedyrt-dette-er-de-viktigste-fremskrittene-innen-behandling-av-sarkom/ 2024-09-16T07:22:31+00:00 https://www.lmi.no/2024/09/16/helsebyradens-vaksineplan-gar-i-vasken-i-oslo/ 2024-09-16T07:23:47+00:00 https://www.lmi.no/2024/09/16/eksport-av-legemidler-og-farmasoytiske-produkter-fra-norge-til-russland-er-pa-sitt-hoyeste-siden-2014/ 2024-09-16T07:25:10+00:00 https://www.lmi.no/2024/09/16/denne-kikhostevaksinen-er-forsinket-til-norge-titusener-star-pa-vent-i-polen/ 2024-09-16T07:26:39+00:00 https://www.lmi.no/2024/09/16/livmorhalskreft-bor-bli-standardbehandling-sa-raskt-som-mulig/ 2024-09-16T07:27:39+00:00 https://www.lmi.no/2024/09/16/nye-xofigo-data-pa-prostatakreft-en-renessanse-for-var-norske-baby/ 2024-09-16T07:28:37+00:00 https://www.lmi.no/2024/09/16/fullt-hus-pa-esmo-da-dmp-fortalte-om-den-norske-prosessen-for-legemiddelgodkjenning/ 2024-09-16T09:23:42+00:00 https://www.lmi.no/2024/09/16/kommunelege-slar-alarm-det-undervurderes/ 2024-09-16T09:36:47+00:00 https://www.lmi.no/2024/09/16/ahus-leger-ble-imponert-av-blaerekreft-data-dette-er-praksisendrende/ 2024-09-16T09:38:02+00:00 https://www.lmi.no/2024/09/16/er-immunterapi-mot-tarmkreft-kostnadseffektivt-biomarkorer-kan-vaere-nokkelen/ 2024-09-16T09:39:32+00:00 https://www.lmi.no/2024/09/16/helsepolitikk-mister-status-og-penger-i-eu/ 2024-09-16T09:41:23+00:00 https://www.lmi.no/2024/09/16/samlet-helseindustri-og-klinikere-i-barcelona/ 2024-09-16T09:42:06+00:00 https://www.lmi.no/wp-content/uploads/2024/09/NorTrials-ESMO-mingling2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/NorTrials-ESMO-mingling-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/NorTrials-ESMO-Jannik-Schmidt-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/NorTrials-ESMO-Signe-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/NorTrials-ESMO-Aslaug-Helland-scaled.jpg https://www.lmi.no/2024/09/16/varsler-anbud-med-okonomisk-motivert-off-label/ 2024-09-16T11:28:15+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Skjermbilde-2024-09-16-125700.png https://www.lmi.no/wp-content/uploads/2024/09/Skjermbilde-2024-09-16-125700.png https://www.lmi.no/2024/07/03/nomvec-feirer-fem-ar/ 2024-09-17T06:08:26+00:00 https://www.lmi.no/wp-content/uploads/2018/12/nomvecBryn1.jpg https://www.lmi.no/wp-content/uploads/2024/07/green_shirt-scaled.jpg https://www.lmi.no/2024/09/17/fagdirektoren-stotter-anbud-pa-ikke-godkjente-legemidler-vi-ma-sette-pasientene-forst/ 2024-09-17T06:33:44+00:00 https://www.lmi.no/2024/09/17/arcticzymes-har-utviklet-enzym-som-kan-fungere-som-molekylsaks/ 2024-09-17T06:35:35+00:00 https://www.lmi.no/2024/09/17/millioner-kan-do-av-antibiotikaresistens/ 2024-09-17T06:36:40+00:00 https://www.lmi.no/2024/09/13/world-patient-safety-day/ 2024-09-17T06:57:53+00:00 https://www.lmi.no/wp-content/uploads/2024/09/World-patient-day-24.png https://www.lmi.no/wp-content/uploads/2024/09/World-patient-day-24.png https://www.lmi.no/wp-content/uploads/2024/09/steps-for-reaching-a-diagnosis-scaled.jpg https://www.lmi.no/2024/09/17/reduserer-risikoen-for-tilbakefall-hos-pasienter-med-tidlig-brystkreft-en-bekreftende-og-viktig-studie/ 2024-09-17T07:10:20+00:00 https://www.lmi.no/2024/09/17/novo-nordisk-inngar-samarbeid-med-britisk-selskap/ 2024-09-17T07:30:05+00:00 https://www.lmi.no/2024/09/17/lmis-innspill-til-allmennlegetjeneste-for-fremtiden/ 2024-09-17T11:40:19+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2024/06/Anne-M-i-stortinget-2.png https://www.lmi.no/2024/09/18/studie-litt-flere-overlever-brystkreft-i-norge-enn-i-danmark/ 2024-09-18T08:43:25+00:00 https://www.lmi.no/2024/09/18/lmi-seniorradgiver-blir-myndighetskontaktsleder-i-astrazeneca/ 2024-09-18T08:44:21+00:00 https://www.lmi.no/2024/09/18/ny-leder-til-emas-komite-for-legemidler-til-sjeldne-sykdommer/ 2024-09-18T08:46:27+00:00 https://www.lmi.no/2024/09/18/ny-type-medisin-mot-lungekreft-jeg-ble-positivt-overrasket/ 2024-09-18T08:47:39+00:00 https://www.lmi.no/2024/09/18/fedme-og-bivirkninger-stjal-overskriftene-pa-diabeteskonferansen-i-madrid/ 2024-09-18T08:49:11+00:00 https://www.lmi.no/2024/09/18/kreftpasienter-gikk-opp-i-vekt-med-legemiddel-pfizer-sikter-mot-fase-3-studie/ 2024-09-18T08:50:40+00:00 https://www.lmi.no/2024/09/18/medlemsundersokelse-2024/ 2024-09-18T09:05:29+00:00 https://www.lmi.no/wp-content/uploads/2024/09/AdobeStock_245160086-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/AdobeStock_245160086-scaled.jpeg https://www.lmi.no/2024/09/18/medwatch-norsk-delegasjon-har-inntatt-nordisk-livsvitenskap-konferanse/ 2024-09-18T11:06:44+00:00 https://www.lmi.no/wp-content/uploads/2024/09/front-MedWatch-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/09/nlsdays-jpg.webp https://www.lmi.no/2024/09/19/norsk-life-science-markerte-seg-i-malmo/ 2024-09-19T11:05:06+00:00 https://www.lmi.no/wp-content/uploads/2024/09/IMG_3719-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/IMG_3719-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/ambassaden-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/3c46ede5-af94-4200-90c0-0453511a57fe.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_3698-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/Link-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_3701-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/IMG_3716-scaled.jpeg https://www.lmi.no/2024/09/20/beslutningsforum-ja-til-car-t-avhenger-av-anbud-pa-ikke-godkjente-legemidler/ 2024-09-20T09:32:32+00:00 https://www.lmi.no/2024/09/20/norsk-delegasjon-har-inntatt-nordisk-livsvitenskap-konferanse/ 2024-09-20T09:36:58+00:00 https://www.lmi.no/2024/09/20/ishita-barua-inn-i-styret-i-wild-norway/ 2024-09-20T09:37:53+00:00 https://www.lmi.no/2024/09/20/ms-legemidler-en-vellykket-norsk-strategi/ 2024-09-20T09:38:55+00:00 https://www.lmi.no/2024/09/20/ny-studie-om-endometriose-%e2%81%a0-ma-folges-opp/ 2024-09-20T09:39:54+00:00 https://www.lmi.no/2024/09/20/ungarsk-advokat-utpekt-som-ny-helsekommissaer-i-eu/ 2024-09-20T09:41:02+00:00 https://www.lmi.no/2024/09/20/prostatakreft-nye-esmo-data-kan-utvide-bruken-av-nubeqa/ 2024-09-20T09:42:10+00:00 https://www.lmi.no/2024/09/20/thermo-fischer-scientific-oppretter-nytt-laboratorium-i-goteborg/ 2024-09-20T09:48:52+00:00 https://www.lmi.no/2024/09/20/har-utlyst-anbudskonkurranse-for-hpv-vaksine/ 2024-09-20T09:50:29+00:00 https://www.lmi.no/2024/09/20/lanserer-ny-fase-3-studie-med-wegovy-arvtager/ 2024-09-20T09:51:23+00:00 https://www.lmi.no/2024/09/20/disse-vil-bli-ekspedisjonssjef-i-hod/ 2024-09-20T09:52:15+00:00 https://www.lmi.no/2024/09/20/jeg-savner-en-helhetlig-tilnaerming-ikke-bare-fokus-pa-lavest-mulig-pris/ 2024-09-20T09:53:15+00:00 https://www.lmi.no/2024/09/20/godkjenning-av-nye-medisiner-er-milliardindustri/ 2024-09-20T09:54:04+00:00 https://www.lmi.no/2024/09/20/ema-vil-oppdatere-pakningsvedlegget-til-wegovy/ 2024-09-20T09:54:53+00:00 https://www.lmi.no/2024/09/20/feiret-fem-ar-med-trygge-legemiddel/ 2024-09-20T14:27:12+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-56.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-56.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-7.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-10.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-26.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-34.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-35.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-39.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-42.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-36.jpg https://www.lmi.no/wp-content/uploads/2024/09/Nomvec-48.jpg https://www.lmi.no/2024/09/23/fem-ar-uten-falske-legemidler-i-norge/ 2024-09-23T06:13:20+00:00 https://www.lmi.no/2024/09/23/hva-bor-norge-bidra-med-for-a-redusere-antibiotikaresistens-krisen/ 2024-09-23T06:14:31+00:00 https://www.lmi.no/2024/09/23/fikk-young-investigator-award-for-sitt-bidrag-pa-ms-kongress/ 2024-09-23T06:16:35+00:00 https://www.lmi.no/2024/09/23/beslutningsforum-skal-vurdere-car-t-behandling-og-btk-hemmere/ 2024-09-23T06:17:27+00:00 https://www.lmi.no/2024/09/23/chmp-anbefaler-atte-nye-legemidler-i-september/ 2024-09-23T06:18:39+00:00 https://www.lmi.no/2024/09/23/kjoper-inn-hpv-vaksiner-for-692-millioner-kroner-effekt-teller-mer-enn-pris/ 2024-09-23T06:20:14+00:00 https://www.lmi.no/2024/09/23/hva-blir-det-neste-etter-keytruda-dette-mener-legemiddeltoppene/ 2024-09-23T06:21:09+00:00 https://www.lmi.no/2024/09/23/kjent-diabetesmedisin-kan-ha-overraskende-effekter-pa-hjernen/ 2024-09-23T06:22:11+00:00 https://www.lmi.no/2024/09/23/toppsjefen-i-novo-nordisk-karet-til-arets-leder-i-europa-av-europeiske-medier/ 2024-09-23T06:23:07+00:00 https://www.lmi.no/2024/09/23/stig-fikk-vite-at-han-hadde-alzheimer-pa-nett-arhundrets-glipp/ 2024-09-23T06:24:40+00:00 https://www.lmi.no/2024/09/23/forskere-kartlegger-hjernens-ukjente-land/ 2024-09-23T06:25:33+00:00 https://www.lmi.no/2024/09/23/adhd-medisiner-kan-drastisk-oke-sjansen-for-psykoser/ 2024-09-23T06:26:35+00:00 https://www.lmi.no/2024/09/23/ekspert-radene-disse-bor-ta-vaksine-na/ 2024-09-23T06:28:33+00:00 https://www.lmi.no/2024/09/23/hjernen-renses-tregere-nar-vi-blir-eldre-na-er-forskere-pa-sporet-av-en-losning/ 2024-09-23T06:30:32+00:00 https://www.lmi.no/2024/09/23/stor-okning-i-pasienter-med-sykelig-overvekt-flere-far-medikamenter-og-ikke-operasjon/ 2024-09-23T06:31:31+00:00 https://www.lmi.no/2024/09/23/novo-nordisk-la-frem-resultater-med-vektreduksjonshap-mer-arbeid-trengs-for-a-finne-optimal-dose/ 2024-09-23T07:07:42+00:00 https://www.lmi.no/2024/09/23/fhi-vi-tar-helsedata-ansvaret-vart-pa-storste-alvor/ 2024-09-23T11:32:29+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Helsedata-frokostseminar-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Helsedata-frokostseminar-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/guri-rortveit3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/helsedatafrokostmote-salen-1-scaled.jpg https://www.lmi.no/2024/09/24/derfor-sa-beslutningsforum-ja-til-kontroversielt-anbud-pa-medisiner/ 2024-09-24T10:24:50+00:00 https://www.lmi.no/2024/09/24/okt-nettleie-vil-koste-vistin-pharma-to-millioner-mer-i-aret-man-tar-effektivt-bort-penger-fra-eksport/ 2024-09-24T10:25:53+00:00 https://www.lmi.no/2024/09/24/eu-vil-gjore-det-lettere-a-ta-biotek-til-markedet-i-kommende-lovforslag/ 2024-09-24T10:28:40+00:00 https://www.lmi.no/2024/09/24/ja-til-medisin-for-pasienter-med-blodpropp-i-oyet/ 2024-09-24T10:29:46+00:00 https://www.lmi.no/2024/09/24/ny-studie-medisin-kan-stoppe-migrenen-for-hodepinen-starter/ 2024-09-24T10:31:29+00:00 https://www.lmi.no/2024/09/24/beslutningsforum-sier-ja-til-atte-av-ni-saker/ 2024-09-24T10:35:13+00:00 https://www.lmi.no/2024/09/24/elahere-med-positive-resultater-i-eggstokkreft-studie/ 2024-09-24T10:36:39+00:00 https://www.lmi.no/2024/09/24/novo-nordisk-salg-av-storselgere-oppveier-snart-tre-tiar-med-forskning/ 2024-09-24T10:39:25+00:00 https://www.lmi.no/2024/09/24/godt-sprak-i-felleskatalogen/ 2024-09-24T10:41:29+00:00 https://www.lmi.no/2024/09/24/lmi-i-hods-dialogmote-om-veien-videre-for-handlingsplanen-for-kliniske-studier/ 2024-09-24T10:57:50+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Forsidebilde-hod-innspill.png https://www.lmi.no/wp-content/uploads/2024/09/Handlingsplanen-for-kliniske-studier.png https://www.lmi.no/wp-content/uploads/2021/01/FLATLA1.jpg https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop-1.png https://www.lmi.no/wp-content/uploads/2024/09/HOd-innspillsmote-foto-signe-scaled.jpeg https://www.lmi.no/2024/09/25/slar-alarm-flere-vil-do/ 2024-09-25T07:42:41+00:00 https://www.lmi.no/2024/09/25/alzheimer-studie-bruk-av-en-type-medisin-kan-forutsi-sykdommen/ 2024-09-25T07:45:47+00:00 https://www.lmi.no/2024/09/25/rapport-hevder-at-koronavaksinene-kan-ha-gjort-folk-langvarig-syke-ikke-mulig-a-sla-fast-sier-forsker/ 2024-09-25T07:47:26+00:00 https://www.lmi.no/2024/09/25/novo-nordisk-toppsjefen-forklarte-seg-i-horing-om-legemiddelpriser/ 2024-09-25T07:49:54+00:00 https://www.lmi.no/2024/09/25/enhertu-oppfolger-bommet-i-klinisk-studie-skaper-tvil-om-godkjenning/ 2024-09-25T07:51:29+00:00 https://www.lmi.no/2024/09/25/urovekkende-funn-slar-alarm/ 2024-09-25T07:55:47+00:00 https://www.lmi.no/2024/09/25/stor-migrenestudie-triptaner-er-best-til-anfallsbehandling/ 2024-09-25T07:58:02+00:00 https://www.lmi.no/2024/09/25/eli-lilly-far-japansk-godkjenning-for-alzheimer-legemiddel/ 2024-09-25T08:01:12+00:00 https://www.lmi.no/2024/09/25/ous-forsker-vant-nordisk-innovasjonskonkurranse/ 2024-09-25T08:04:13+00:00 https://www.lmi.no/2024/09/25/jj-om-kontroversielt-anbud-lite-tillitsvekkende-og-uforutsigbart/ 2024-09-25T08:06:18+00:00 https://www.lmi.no/2024/09/25/fikk-tommelen-ned-fra-beslutningsforum-stiller-oss-undrende-til-beslutningen/ 2024-09-25T08:07:47+00:00 https://www.lmi.no/2024/09/25/arctic-bioscience-viser-frem-effekt-i-celledata-pa-europeisk-kongress/ 2024-09-25T08:09:29+00:00 https://www.lmi.no/2024/09/25/farmasistudenter-er-morgendagens-kolleger-og-kunder-na-laerer-de-mer-om-industrien/ 2024-09-25T18:43:29+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Oslo-Met-Bayer-crop-2.png https://www.lmi.no/wp-content/uploads/2024/09/Oslo-Met-Sanofi.png https://www.lmi.no/wp-content/uploads/2024/09/OsloMet-Bayer-crop.png https://www.lmi.no/2024/09/26/msds-behandling-mot-tykktarmskreft-mislykkes-i-en-senfase-studie/ 2024-09-26T07:47:18+00:00 https://www.lmi.no/2024/09/26/legemidler-og-lys-fascinerte-bade-unge-og-gamle-under-forskningsdagene/ 2024-09-26T07:48:10+00:00 https://www.lmi.no/2024/09/26/exact-therapeutics-far-innvilget-patent-i-storbritannia/ 2024-09-26T07:49:26+00:00 https://www.lmi.no/2024/09/26/immunterapi-star-sterkt-mer-enn-ti-ar-etter-forste-godkjenning-en-enorm-utvikling/ 2024-09-26T07:50:42+00:00 https://www.lmi.no/2024/09/26/astrazeneca-kandidat-skuffer-i-brystkreftstudie/ 2024-09-26T07:52:23+00:00 https://www.lmi.no/2024/09/26/ny-forskning-ozempic-kan-forbedre-en-vanlig-og-kronisk-hudsykdom/ 2024-09-26T07:53:43+00:00 https://www.lmi.no/2024/09/26/pfizer-trekker-sigdcelleanemi-behandling-fra-alle-markeder-den-er-godkjent-i/ 2024-09-26T07:54:50+00:00 https://www.lmi.no/2024/09/26/forskningsradet-deler-ut-13-milliarder-kroner/ 2024-09-26T07:56:38+00:00 https://www.lmi.no/2024/09/26/lanserer-ny-strategi-mot-antimikrobiell-resistens/ 2024-09-26T08:04:03+00:00 https://www.lmi.no/2024/09/25/lanserte-ny-strategi-mot-antimikrobiell-resistens/ 2024-09-26T08:46:31+00:00 https://www.lmi.no/wp-content/uploads/2024/09/AMR-reax.png https://www.lmi.no/wp-content/uploads/2024/09/AMR-reax.png https://www.lmi.no/2024/09/26/husk-a-melde-deg-pa-lov-og-bransjekurs-hosten-2024/ 2024-09-26T10:33:51+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/2024/09/26/helseokonomikonferansen-trenger-en-pragmatisk-tilnaerming/ 2024-09-26T11:31:19+00:00 https://www.lmi.no/wp-content/uploads/2024/09/IMG_2062.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_2062.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_2050-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/IMG_2064.jpg https://www.lmi.no/2024/09/26/science-impact-2024/ 2024-09-27T07:58:29+00:00 https://www.lmi.no/wp-content/uploads/2024/09/masse-Mingel-AN-40-copy-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/hilde-growhouse3-AN-58-copy.jpg https://www.lmi.no/wp-content/uploads/2024/09/wolber-growhouse1-AN-23-copy-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/masse-Mingel-AN-40-copy-scaled.jpg https://www.lmi.no/2024/09/27/atopisk-eksem-opprettholdt-klar-hud-etter-tre-ar-med-antistoff-behandling/ 2024-09-27T09:41:14+00:00 https://www.lmi.no/2024/09/27/rab-diagnostics-vant-pitchekonkurranse/ 2024-09-27T09:42:21+00:00 https://www.lmi.no/2024/09/27/medie-johnson-johnson-reduserer-kardiovaskulaer-enhet/ 2024-09-27T09:46:57+00:00 https://www.lmi.no/2024/09/27/onsker-a-gi-gratis-vaksine-et-samfunnsproblem/ 2024-09-27T09:47:48+00:00 https://www.lmi.no/2024/09/27/gar-motstroms-med-nytt-selskap/ 2024-09-27T09:48:57+00:00 https://www.lmi.no/2024/09/27/svettekjertelbetennelse-nye-legemidler-gir-nye-anbefalinger-for-behandling/ 2024-09-27T09:50:06+00:00 https://www.lmi.no/2024/09/27/lege-fikk-utbetalt-en-halv-milliard-kroner-fra-legemiddelselskap/ 2024-09-27T09:50:57+00:00 https://www.lmi.no/2024/09/27/medwatch-trygve-ottersen-blir-ny-direktor-i-dmp/ 2024-09-27T10:31:01+00:00 https://www.lmi.no/wp-content/uploads/2024/09/ottersen1-jpg.webp https://www.lmi.no/wp-content/uploads/2024/09/ottersen1-jpg-1.webp https://www.lmi.no/2024/09/30/skal-kaste-lys-over-utbredt-kvinnesykdom/ 2024-09-30T07:05:37+00:00 https://www.lmi.no/2024/09/30/fda-godkjenner-forste-nye-schizofreni-medisin-pa-flere-tiar/ 2024-09-30T07:07:33+00:00 https://www.lmi.no/2024/09/30/trusselen-om-antibiotikaresistens-stiger-forskere-kan-ha-funnet-losning-i-vare-egne-kropper/ 2024-09-30T07:08:38+00:00 https://www.lmi.no/2024/09/30/vaksinestriden-mellom-moderna-og-pfizer-fortsetter-pfizer-kan-anke/ 2024-09-30T07:09:35+00:00 https://www.lmi.no/2024/09/30/na-er-det-viktig-a-presse-politikerne-pa-antibiotikaresistens/ 2024-09-30T07:10:27+00:00 https://www.lmi.no/2024/09/30/novo-nordisk-sendt-til-bunns-av-jpmorgan-analytikere-frykter-wegovy-skuffelse/ 2024-09-30T07:11:31+00:00 https://www.lmi.no/2024/09/30/snart-kan-ein-mala-effekten-av-kreftbehandling-fra-utsida-av-pasienten/ 2024-09-30T07:12:29+00:00 https://www.lmi.no/2024/09/30/norske-apoteker-omsatte-for-17-milliarder-i-forste-halvar/ 2024-09-30T07:13:36+00:00 https://www.lmi.no/2024/09/30/slik-gikk-det-med-myndighetenes-slankeplan/ 2024-09-30T07:15:07+00:00 https://www.lmi.no/2024/09/30/skandale-ryster-medisinverden-summer-man-blir-svimle-av/ 2024-09-30T07:16:09+00:00 https://www.lmi.no/2024/09/30/presentasjoner-fra-dra-forum-2024/ 2024-09-30T17:38:29+00:00 https://www.lmi.no/2024/10/01/dette-er-aps-lofter-til-helsenaeringen-vil-opprette-helsekatapult/ 2024-10-01T10:29:01+00:00 https://www.lmi.no/2024/10/01/astrazeneca-har-inngatt-ki-avtale-med-amerikansk-selskap/ 2024-10-01T10:31:02+00:00 https://www.lmi.no/2024/10/01/kunstig-intelligens-skal-lose-kreftgatens-utfordringer/ 2024-10-01T10:32:23+00:00 https://www.lmi.no/2024/10/01/curida-direktoren-advarer-om-svekket-konkurransekraft-etter-okning-i-nettleie/ 2024-10-01T10:33:48+00:00 https://www.lmi.no/2024/10/01/kvinne-kurert-for-diabetes-med-middel-fra-sin-egen-kropp/ 2024-10-01T10:35:11+00:00 https://www.lmi.no/2024/10/01/han-blir-ny-leder-for-chmp/ 2024-10-01T10:36:21+00:00 https://www.lmi.no/2024/10/01/roche-tror-fedme-kandidater-vil-vaere-verdt-over-tre-milliarder-dollar-i-aret/ 2024-10-01T10:37:17+00:00 https://www.lmi.no/2024/10/01/barbara-suter-pa-plass-i-lmi/ 2024-10-01T11:31:49+00:00 https://www.lmi.no/wp-content/uploads/2024/10/IMG_34823.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_34823.jpg https://www.lmi.no/2024/10/03/pfizer-har-solgt-aksjer-i-britiske-haleon-for-33-milliarder-kroner/ 2024-10-03T09:24:23+00:00 https://www.lmi.no/2024/10/03/gar-til-ny-nordisk-stilling-i-ucb-pharma/ 2024-10-03T09:25:46+00:00 https://www.lmi.no/2024/10/03/nettleieokningen-skremmer-ikke-arctic-bioscience-sjefen-ma-likevel-oke-prisene/ 2024-10-03T09:26:39+00:00 https://www.lmi.no/2024/10/03/lupus-syke-tu-thao-trodde-hun-skulle-do-en-helt-ny-type-behandling-reddet-livet-hennes/ 2024-10-03T09:28:46+00:00 https://www.lmi.no/2024/10/03/radiofarmasi-selskap-henter-18-milliarder-kroner-fra-store-legemiddelselskaper/ 2024-10-03T09:30:04+00:00 https://www.lmi.no/2024/10/03/ema-vil-ha-en-mer-effektiv-prosess-for-markedsforingstillatelse-antallet-clock-stop-dager-oker/ 2024-10-03T09:31:03+00:00 https://www.lmi.no/2024/10/03/who-anbefaler-vaksinasjon-og-antistoffbehandling-mot-rsv-for-gravide-og-spedbarn/ 2024-10-03T09:32:01+00:00 https://www.lmi.no/2024/10/04/medwatch-lmi-etterlyser-eksportloft-i-statsbudsjettet-hvis-det-ikke-kommer-na-har-naeringen-blitt-fort-bak-lyset/ 2024-10-04T10:58:21+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skjermbilde-2024-10-04-124422.png https://www.lmi.no/wp-content/uploads/2024/10/Skjermbilde-2024-10-04-124422-1.png https://www.lmi.no/2024/10/04/eli-lilly-investerer-over-47-milliarder-kroner-i-nytt-anlegg/ 2024-10-04T11:06:26+00:00 https://www.lmi.no/2024/10/04/kvinnehelsestrategien-vil-gi-storre-muligheter-for-individuell-refusjon-for-hormonbehandling-i-overgangsalderen/ 2024-10-04T11:07:48+00:00 https://www.lmi.no/2024/10/04/dette-er-de-viktigste-fremskrittene-innen-forskning-pa-multippel-sklerose-ms/ 2024-10-04T11:08:46+00:00 https://www.lmi.no/2024/10/04/etterlyser-status-for-voksenvaksinasjonsprogram/ 2024-10-04T11:09:50+00:00 https://www.lmi.no/2024/10/04/who-godkjenner-den-forste-diagnostiske-testen-for-m-kopper-til-nodstilfeller/ 2024-10-04T11:10:49+00:00 https://www.lmi.no/2024/10/07/thermo-fisher-har-brutt-fda-regler-ved-sitt-storste-produksjonsanlegg/ 2024-10-07T10:52:39+00:00 https://www.lmi.no/2024/10/07/statsbudsjettet-2025-kreftforeningen-krever-at-regjeringen-innfrir-loftene/ 2024-10-07T10:53:37+00:00 https://www.lmi.no/2024/10/07/hvorfor-far-ikke-norske-kreftpasienter-delta-i-behandlingsstudier-i-sverige-og-danmark/ 2024-10-07T10:54:53+00:00 https://www.lmi.no/2024/10/07/nye-medisinske-gjennombrudd-utfordrer-systemet/ 2024-10-07T10:57:12+00:00 https://www.lmi.no/2024/10/07/novartis-vi-trenger-et-ventetidsloft-for-nye-medisiner/ 2024-10-07T10:58:25+00:00 https://www.lmi.no/2024/10/07/novo-nordisk-investerer-over-15-milliarder-kroner-i-fabrikk-i-brasil/ 2024-10-07T10:59:51+00:00 https://www.lmi.no/2024/10/07/bergenbio-med-nye-data-fra-lungekreftstudie/ 2024-10-07T11:00:58+00:00 https://www.lmi.no/2024/10/07/lmi-gleder-seg-over-voksenvaksinasjonsprogram-et-kjempesteg/ 2024-10-07T11:05:09+00:00 https://www.lmi.no/2024/10/07/her-er-regjeringens-forslag-til-helsebudsjett-for-2025/ 2024-10-07T11:06:57+00:00 https://www.lmi.no/2024/10/07/regjeringen-letter-pa-formueskatten-veldig-kosmetisk/ 2024-10-07T11:08:09+00:00 https://www.lmi.no/2024/10/07/skymoen-direkte-pa-tv2-et-gladsak-i-budsjettet/ 2024-10-07T12:14:03+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-pa-tv2_2_statsbudsjettet.png https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-pa-tv2_2_statsbudsjettet.png https://www.lmi.no/2024/10/07/statsbudsjettet-2025-trenger-mer-muskler-i-satsingen-pa-helseindustrien/ 2024-10-07T12:51:07+00:00 https://www.lmi.no/wp-content/uploads/2023/10/stortinget-Leif-Rune-Skymoen-Monica-Larsen-2926-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/stortinget-Leif-Rune-Skymoen-Monica-Larsen-2926-scaled.jpg https://www.lmi.no/2024/10/07/statsbudsjettet-2025-her-er-de-viktigste-hovedpunktene/ 2024-10-07T13:05:33+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-med-Vestre_statsbudsjettet-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-med-Vestre_statsbudsjettet-2025-scaled.jpg https://www.lmi.no/2024/10/07/endelig-en-forsiktig-start-pa-et-voksenvaksinasjonsprogram/ 2024-10-07T13:08:44+00:00 https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/06/Anne-M-i-stortinget-2.png https://www.lmi.no/2024/10/07/ny-sammensetning-av-lmis-gruppe-for-ra-og-pv/ 2024-10-07T13:13:10+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Faggruppen-for-regulatory-og-pharmacovigilance-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Faggruppen-for-regulatory-og-pharmacovigilance-scaled.jpg https://www.lmi.no/2024/10/03/forskningsdagene-2024-folkeopplysning-om-kliniske-studier/ 2024-10-07T14:29:41+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Forskningsdagene-Ahus-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Forskningsdagene-Ahus-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Forskningsdagene-Bergen_edited.jpg https://www.lmi.no/wp-content/uploads/2024/10/Panel-Forskningsdagene-Kreftforeningen-scaled.jpg https://www.lmi.no/2024/10/07/forskningsdagene-2024-folkeopplysning-om-kliniske-studier-2/ 2024-10-07T14:34:11+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Panel-Forskningsdagene-Kreftforeningen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/Panel-Forskningsdagene-Kreftforeningen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Forskningsdagene-Ahus-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/Forskningsdagene-Bergen_edited.jpg https://www.lmi.no/2024/10/07/lmi-om-antibiotikaresistens-i-tidsskriftet-genialt/ 2024-10-07T15:00:53+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Anne-Margrethe-i-Genialt.png https://www.lmi.no/wp-content/uploads/2024/10/Anne-Margrethe-i-Genialt.png https://www.lmi.no/2024/10/08/nytt-forskningsprosjekt-om-biologiske-legemidler-dette-blir-et-nasjonalt-loft/ 2024-10-08T09:54:54+00:00 https://www.lmi.no/2024/10/08/kreftforeningen-skuffet-over-manglende-helsekatapult-vil-vaere-med-pa-spleiselaget/ 2024-10-08T09:56:13+00:00 https://www.lmi.no/2024/10/08/500-millioner-kroner-til-direktoratet-for-medisinske-produkter/ 2024-10-08T09:57:26+00:00 https://www.lmi.no/2024/10/08/hudlege-hardt-ut-mot-dmp/ 2024-10-08T09:59:28+00:00 https://www.lmi.no/2024/10/08/ber-helsepersonell-vaksinere-seg-ulikheter-mellom-yrkesgrupper/ 2024-10-08T10:00:47+00:00 https://www.lmi.no/2024/10/08/navamedic-vant-fellesnordisk-anbud-pa-antibiotika-skal-levere-til-tre-land/ 2024-10-08T10:05:20+00:00 https://www.lmi.no/2024/10/08/nordicrwe-er-forste-norske-selskap-i-astrazenecas-innovasjonshub-i-goteborg/ 2024-10-08T10:06:15+00:00 https://www.lmi.no/2024/10/08/fra-norge-til-europa/ 2024-10-08T13:28:51+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Kai-3.jpg https://www.lmi.no/wp-content/uploads/2024/10/Kai-3.jpg https://www.lmi.no/2024/10/08/felleskatalogens-bivirkningssok-pa-agendaen-i-helsinki/ 2024-10-08T14:19:29+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Bente-pa-talerstolen-i-Helsinki.jpg https://www.lmi.no/wp-content/uploads/2024/10/Bente-pa-talerstolen-i-Helsinki.jpg https://www.lmi.no/wp-content/uploads/2024/10/Pharmacovigilance-damer-i-Helsinki-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/Bente-og-DMP-i-Helsinki.jpg https://www.lmi.no/2024/10/09/thor-medical-lager-kreftlegemidlenes-stridshoder/ 2024-10-09T08:37:57+00:00 https://www.lmi.no/2024/10/09/girer-opp-forskningen-pa-radiofarmaka-med-superskanner/ 2024-10-09T08:39:29+00:00 https://www.lmi.no/2024/10/09/agilera-vil-vaere-med-pa-det-radioaktive-kapplopet/ 2024-10-09T08:40:53+00:00 https://www.lmi.no/2024/10/09/na-vokser-radiofarmakamarkedet-kraftig-hvor-star-norge/ 2024-10-09T08:43:13+00:00 https://www.lmi.no/2024/10/09/hap-om-vaksine-mot-dodelig-virus/ 2024-10-09T08:44:42+00:00 https://www.lmi.no/2024/10/09/diabetiker-lager-sitt-eget-insulin-etter-a-ha-fatt-satt-inn-dyrkede-celler/ 2024-10-09T08:45:35+00:00 https://www.lmi.no/2024/10/09/slik-far-du-magesar-og-sure-oppstot-fra-investeringer-i-biotek/ 2024-10-09T08:47:52+00:00 https://www.lmi.no/2024/10/09/nomvec-sjef-kai-mjaanes-drar-til-brussel-for-europeisk-toppjobb/ 2024-10-09T08:50:27+00:00 https://www.lmi.no/2024/10/09/har-inngatt-ny-nordisk-avtale-om-antibitioka/ 2024-10-09T08:51:42+00:00 https://www.lmi.no/2024/10/09/malrettet-terapi-med-radiofarmasi/ 2024-10-09T08:54:47+00:00 https://www.lmi.no/2024/10/09/aktivist-investor-kjoper-seg-inn-i-pfizer-for-milliarder/ 2024-10-09T09:15:10+00:00 https://www.lmi.no/2024/10/09/exact-therapeutics-inngar-samarbeid-med-amerikanske-agenus/ 2024-10-09T09:16:10+00:00 https://www.lmi.no/2024/10/09/pentagon-vil-investere-500-millioner-dollar-arlig-i-kvinnehelseforskning/ 2024-10-09T09:17:04+00:00 https://www.lmi.no/2024/10/09/lmis-horingssvar-krav-om-bakgrunnssjekk/ 2024-10-09T10:24:37+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2024/09/Helsedata-3-scaled.jpeg https://www.lmi.no/2024/10/10/problemer-med-lmis-nyhetsbrev/ 2024-10-10T10:34:00+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skjermbilde-2024-10-10-123121.png https://www.lmi.no/wp-content/uploads/2024/10/Skjermbilde-2024-10-10-123121.png https://www.lmi.no/2024/10/10/nesten-hele-europa-har-byttet-hpv-vaksine-men-ikke-norge/ 2024-10-10T10:48:47+00:00 https://www.lmi.no/2024/10/10/vil-flytte-legeoppgaver-til-apotekene-sables-ned-av-legene/ 2024-10-10T10:49:40+00:00 https://www.lmi.no/2024/10/10/dmp-vil-fortsatt-ha-ibuprofen-i-butikk/ 2024-10-10T10:50:37+00:00 https://www.lmi.no/2024/10/10/dyrere-hpv-vaksine-vil-bli-billigere-for-samfunnet-pa-sikt/ 2024-10-10T10:51:48+00:00 https://www.lmi.no/2024/10/10/ge-healthcare-med-lovende-resultater-for-norskutviklet-kontrastmiddel/ 2024-10-10T10:52:52+00:00 https://www.lmi.no/2024/10/10/leo-pharma-gjor-ny-kuttrunde-rammer-ikke-norsk-avdeling/ 2024-10-10T10:53:49+00:00 https://www.lmi.no/2024/10/10/pfizer-gar-i-dialog-med-aktivist-investor/ 2024-10-10T10:54:46+00:00 https://www.lmi.no/2024/10/11/regjeringen-bevilger-237-millioner-til-forskning-pa-bioteknologi-ikt-og-nanoteknologi/ 2024-10-11T07:52:18+00:00 https://www.lmi.no/2024/10/11/studie-psoriasis-koblet-til-dodelig-sykdom/ 2024-10-11T07:53:34+00:00 https://www.lmi.no/2024/10/11/bergenbio-direktoren-gar-av/ 2024-10-11T07:56:52+00:00 https://www.lmi.no/2024/10/11/oncoinvent-har-dosert-forste-pasient-i-kreftstudie/ 2024-10-11T08:36:59+00:00 https://www.lmi.no/2024/10/11/britisk-legemiddelgigant-stiger-kraftig-etter-milliardavtale/ 2024-10-11T08:38:04+00:00 https://www.lmi.no/2024/10/11/ingen-eksterne-eksperter-i-spesialistgruppe-for-anbud-pa-hpv-vaksine/ 2024-10-11T08:39:12+00:00 https://www.lmi.no/2024/10/11/har-ansatt-sin-aller-forste-ki-direktor/ 2024-10-11T08:40:19+00:00 https://www.lmi.no/2024/10/14/politikerne-ma-pa-banen-hvis-hpv-vaksinene-skal-vurderes-pa-en-annen-mate/ 2024-10-14T08:49:00+00:00 https://www.lmi.no/2024/10/14/roche-far-fda-godkjenning-for-brystkreft-behandling/ 2024-10-14T08:52:28+00:00 https://www.lmi.no/2024/10/14/bayer-ma-betale-78-millioner-dollar-til-mann-i-roundup-rettsak/ 2024-10-14T08:56:21+00:00 https://www.lmi.no/2024/10/14/slik-kan-ki-gi-mer-presise-diagnoser-og-raskere-utvikling-av-legemidler/ 2024-10-14T08:58:58+00:00 https://www.lmi.no/2024/10/14/ny-fabrikk-vil-lage-effektiv-medisin-den-gylne-draumen-i-kreftmedisin/ 2024-10-14T09:00:51+00:00 https://www.lmi.no/2024/10/14/novo-nordisk-kan-fa-mange-utfordrere-innen-fedme-i-2029/ 2024-10-14T09:02:07+00:00 https://www.lmi.no/2024/10/14/vil-gjore-det-enklere-a-bruke-helsedata-foreslar-flere-lovendringer/ 2024-10-14T09:03:01+00:00 https://www.lmi.no/2024/10/14/blir-ekspedisjonssjef-for-ny-avdeling-i-helse-og-omsorgsdepartementet/ 2024-10-14T09:07:06+00:00 https://www.lmi.no/2024/10/14/calluna-pharma-far-ny-administrerende-direktor-og-styreleder/ 2024-10-14T09:08:14+00:00 https://www.lmi.no/2024/10/14/ny-parkinsonmedisin-reduserer-sykdomsbyrden/ 2024-10-14T09:09:15+00:00 https://www.lmi.no/2024/10/14/lmi-onsker-gentili-pharma-velkommen-som-nytt-medlem/ 2024-10-14T09:28:59+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Gentili-Pharma-i-Milano_edited.jpg https://www.lmi.no/wp-content/uploads/2024/10/Gentili-Pharma-i-Milano_edited.jpg https://www.lmi.no/2024/10/15/who-godkjenner-bavarians-m-koppevaksine-for-unge-mellom-12-og-17/ 2024-10-15T08:54:55+00:00 https://www.lmi.no/2024/10/15/okning-i-netteleiepris-gir-millionregning-for-norges-storste-legemiddelprodusent/ 2024-10-15T08:56:10+00:00 https://www.lmi.no/2024/10/15/proppfulle-av-virus-helt-vilt/ 2024-10-15T08:57:30+00:00 https://www.lmi.no/2024/10/15/lundbeck-kjoper-amerikansk-biotekselskap-i-milliardhandel/ 2024-10-15T08:59:26+00:00 https://www.lmi.no/2024/10/15/dmp-om-hpv-kritikken-vi-tar-det-med-oss-videre/ 2024-10-15T09:01:09+00:00 https://www.lmi.no/2024/10/15/nytt-anbud-pa-kolesterolsenkende-medisiner-overlege-onsker-seg-en-ny-kostnadsanalyse/ 2024-10-15T09:03:24+00:00 https://www.lmi.no/2024/10/15/arctic-bioscience-motte-ikke-primaerendepunktet-venter-pa-helarsdata/ 2024-10-15T09:04:46+00:00 https://www.lmi.no/2024/10/01/husk-a-melde-deg-pa-regulatorisk-hostmote/ 2024-10-15T09:22:59+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Illustrasjon-regmotet.png https://www.lmi.no/wp-content/uploads/2024/10/Illustrasjon-regmotet.png https://www.lmi.no/2024/10/15/har-loftet-sporsmalet-om-off-label-til-efpia/ 2024-10-15T11:46:26+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Norske-sedler.jpeg https://www.lmi.no/wp-content/uploads/2024/10/Norske-sedler.jpeg https://www.lmi.no/2024/10/14/lmi-i-horing-om-helsebudsjettet-for-2025/ 2024-10-15T13:58:50+00:00 https://www.lmi.no/wp-content/uploads/2024/10/LRogThordis2.png https://www.lmi.no/wp-content/uploads/2024/10/LRogThordis2.png https://www.lmi.no/2024/10/16/lmi-i-healthtalk-om-okonomisk-motivert-off-label/ 2024-10-16T08:02:57+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skjermbilde-2024-10-16-093031.png https://www.lmi.no/wp-content/uploads/2024/10/HealthTalkFRONT.png https://www.lmi.no/2024/10/16/sendte-reprise-av-ekspertpanel-pa-voksenvaksinasjonsprogram/ 2024-10-16T08:33:11+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Ekko-vaksiner-2048x2008-1.jpg https://www.lmi.no/wp-content/uploads/2024/10/Ekko-vaksiner-2048x2008-1.jpg https://www.lmi.no/2024/10/16/10-ar-med-kliniske-studier-pa-benmargskreft-dette-vil-fredrik-schjesvold-fa-til-de-neste-ti-arene/ 2024-10-16T09:50:53+00:00 https://www.lmi.no/2024/10/16/ulceros-kolitt-ekspertene-deler-innsikt-om-effektiv-behandling/ 2024-10-16T09:51:58+00:00 https://www.lmi.no/2024/10/16/amgen-vant-anbudskonkurransen-pa-kolesterolsenkende-legemidler/ 2024-10-16T09:52:54+00:00 https://www.lmi.no/2024/10/16/bayer-soker-om-markedsforingstillatelse-i-europa-for-legemiddel-mot-hetetokter/ 2024-10-16T09:53:57+00:00 https://www.lmi.no/2024/10/16/et-svaert-alvorlig-prinsippbrudd/ 2024-10-16T09:55:48+00:00 https://www.lmi.no/2024/10/16/ema-vil-innfore-strengere-regler/ 2024-10-16T09:56:50+00:00 https://www.lmi.no/2024/10/09/medlemsmote-om-lmis-prioriteringer-og-actions/ 2024-10-16T10:05:23+00:00 https://www.lmi.no/wp-content/uploads/2024/10/AdobeStock_245160086-scaled.jpeg https://www.lmi.no/2024/10/16/velkommen-til-drug-safety-forum-2024/ 2024-10-16T11:01:21+00:00 https://www.lmi.no/wp-content/uploads/2024/10/AdobeStock_konferansesal-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/AdobeStock_konferansesal-scaled.jpeg https://www.lmi.no/2024/10/17/lmi-i-horing-pa-naeringsbudsjettet-for-2025/ 2024-10-17T19:48:40+00:00 https://www.lmi.no/wp-content/uploads/2024/10/LRogThordisNaering1.png https://www.lmi.no/wp-content/uploads/2024/10/LRogThordisNaering1.png https://www.lmi.no/2024/10/18/skal-forske-pa-slankemedisinerog-arbeidsledighet/ 2024-10-18T08:29:54+00:00 https://www.lmi.no/2024/10/18/departementet-opphevet-seks-av-ni-refusjonsvedtak/ 2024-10-18T08:33:30+00:00 https://www.lmi.no/2024/10/18/lmi-mener-dmp-ma-endre-praksis/ 2024-10-18T08:34:31+00:00 https://www.lmi.no/2024/10/18/dmp-vi-tar-det-til-laering-i-nye-saker/ 2024-10-18T08:35:44+00:00 https://www.lmi.no/2024/10/18/slar-alarm-etter-kartlegging-av-andelen-kvinner-i-livsvitenskapsbransjen/ 2024-10-18T08:36:42+00:00 https://www.lmi.no/2024/10/18/beslutningsforum-ny-vurdering-av-ms-medisin-og-blir-det-ja-til-behandling-av-alvorlig-haravfall/ 2024-10-18T08:37:56+00:00 https://www.lmi.no/2024/10/18/dmp-ingen-automatikk-i-at-vi-gjor-nye-kostnadsanalyser/ 2024-10-18T08:39:51+00:00 https://www.lmi.no/2024/10/18/tidligere-oncoinvent-direktor-har-fatt-ny-jobb-i-sverige/ 2024-10-18T08:41:26+00:00 https://www.lmi.no/2024/10/15/frokostmote-hvordan-skrive-en-god-helsedatasoknad/ 2024-10-18T08:54:10+00:00 https://www.lmi.no/wp-content/uploads/2024/09/Helsedata-3-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/Helsedata-crop.png https://www.lmi.no/2024/10/18/medlemsmotet-om-lmis-prioriteringer-og-actions/ 2024-10-18T11:12:23+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Medlemsmotet-18110-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/10/Medlemsmotet-1810.png https://www.lmi.no/2024/10/21/legemiddelselskapet-mener-lang-behandlingstid-pa-refusjonssoknad-gjorde-investering-i-norsk-avdeling-uholdbar/ 2024-10-21T06:19:12+00:00 https://www.lmi.no/2024/10/21/pfizer-etterlyser-bedre-dialog-etter-refusjons-nei/ 2024-10-21T06:20:12+00:00 https://www.lmi.no/2024/10/21/dette-er-sakene-beslutningsforum-skal-vurdere/ 2024-10-21T06:33:43+00:00 https://www.lmi.no/2024/10/21/chmp-anbefaler-ti-nye-legemidler/ 2024-10-21T06:40:08+00:00 https://www.lmi.no/2024/10/21/beslutningsforum-skal-vurdere-sterkt-onsket-kreftmedisin-og-ms-medisin/ 2024-10-21T06:42:19+00:00 https://www.lmi.no/2024/10/21/alzheimers-utvikler-seg-i-to-stadier-her-oppstar-sykdommen-forst/ 2024-10-21T06:43:44+00:00 https://www.lmi.no/2024/10/21/oppsiktsvekkende-fedme-tall-vi-burde-gjort-mer/ 2024-10-21T06:44:51+00:00 https://www.lmi.no/2024/10/21/helsenaeringen-er-verdifull-for-norge/ 2024-10-21T06:46:27+00:00 https://www.lmi.no/2024/10/21/har-ventet-1000-dager-pa-behandling/ 2024-10-21T06:47:22+00:00 https://www.lmi.no/2024/10/21/vil-gi-arbeidsledige-slankemedisin/ 2024-10-21T06:49:07+00:00 https://www.lmi.no/2024/10/21/fikk-sjokk-da-han-tok-slankemedisin-%e2%81%a0-noe-er-galt/ 2024-10-21T06:49:51+00:00 https://www.lmi.no/2024/10/21/lmi-og-nho-i-altinget-helsenaeringen-er-verdifull-for-norge/ 2024-10-21T07:05:51+00:00 https://www.lmi.no/wp-content/uploads/2024/10/AltingetHelsenaering.png https://www.lmi.no/wp-content/uploads/2024/10/AltingetHelsenaering.png https://www.lmi.no/2024/10/21/inflammatorisk-tarmsykdom-mange-far-ikke-kontroll-pa-sykdommen/ 2024-10-21T07:09:17+00:00 https://www.lmi.no/2024/10/21/sykehusinnkjop-avlyser-milliardanbud/ 2024-10-21T07:43:20+00:00 https://www.lmi.no/2024/08/26/strategisamling-2024/ 2024-10-21T10:21:10+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Strategisamling.jpg https://www.lmi.no/wp-content/uploads/2024/10/Strategisamling.jpg https://www.lmi.no/2024/10/21/velkommen-til-frokostmote-om-blareseptanbud/ 2024-10-21T11:11:30+00:00 https://www.lmi.no/wp-content/uploads/2024/10/blaresept-1.jpg https://www.lmi.no/2024/10/22/mener-refusjons-tidsbruk-kan-gjore-norge-mindre-attraktivt-for-selskaper/ 2024-10-22T08:15:11+00:00 https://www.lmi.no/2024/10/22/ms-forbundet-en-veldig-god-og-viktig-nyhet/ 2024-10-22T08:16:10+00:00 https://www.lmi.no/2024/10/22/ny-hjelp-mot-atopisk-eksem/ 2024-10-22T08:17:44+00:00 https://www.lmi.no/2024/10/22/na-vil-forskere-fjernstyre-hjernen-til-parkinson-pasienter/ 2024-10-22T08:18:40+00:00 https://www.lmi.no/2024/10/22/kolesterolsenkende-medisiner-kan-virke-mot-migrene/ 2024-10-22T08:19:48+00:00 https://www.lmi.no/2024/10/22/faerre-reservasjoner-mot-medisinbytte/ 2024-10-22T08:21:05+00:00 https://www.lmi.no/2024/10/22/nei-til-kombo-behandling-mot-blodkreft-for-hoy-pris-pa-de-to-legemidlene/ 2024-10-22T08:22:14+00:00 https://www.lmi.no/2024/10/22/gir-ikke-opp-etter-nei-til-haravfall-medisin-vi-skal-kjempe-videre/ 2024-10-22T08:23:05+00:00 https://www.lmi.no/2024/10/22/ema-og-europakommisjonen-skal-jobbe-tettere-med-metodevurderinger/ 2024-10-22T08:24:00+00:00 https://www.lmi.no/2024/10/22/beslutningsforum-sier-ja-til-ni-og-nei-til-seks-legemidler/ 2024-10-22T08:25:47+00:00 https://www.lmi.no/2024/10/22/sykehusinnkjop-utlyser-legemiddelanbud/ 2024-10-22T08:26:41+00:00 https://www.lmi.no/2024/10/22/ous-forsker-vil-vise-om-hiv-medisin-virker-mot-ms-far-millioner-til-forskningen/ 2024-10-22T08:27:32+00:00 https://www.lmi.no/2024/10/22/lmis-forelopige-gjennomslag-i-partiprogrammene/ 2024-10-22T12:33:58+00:00 https://www.lmi.no/wp-content/uploads/2017/03/Stortinget.jpg https://www.lmi.no/wp-content/uploads/2017/03/Stortinget.jpg https://www.lmi.no/2024/10/23/europa-mister-fortsatt-fotfeste-innen-kliniske-studier/ 2024-10-23T07:59:59+00:00 https://www.lmi.no/2024/10/23/amerikansk-radiofarmasi-produsent-vil-doble-kapasiteten/ 2024-10-23T08:00:59+00:00 https://www.lmi.no/2024/10/23/influenser-og-komiker-reklamerte-ulovlig-for-legemidler/ 2024-10-23T08:03:18+00:00 https://www.lmi.no/2024/10/23/crohns-tidlig-aggressiv-behandling-avgjorende-for-a-forhindre-ytterligere-skade-pa-tarmen/ 2024-10-23T08:04:13+00:00 https://www.lmi.no/2024/10/23/alzheimer-legemiddel-far-nei-i-australia/ 2024-10-23T08:05:06+00:00 https://www.lmi.no/2024/10/23/dansk-konsulentselskap-ser-okende-behov-for-metodevurderinger-etablerer-seg-i-norge/ 2024-10-23T08:05:59+00:00 https://www.lmi.no/2024/10/23/roche-leverte-bedre-salg-enn-ventet/ 2024-10-23T08:06:56+00:00 https://www.lmi.no/2024/10/23/eli-lillys-alzheimer-legemiddel-kan-fa-nei-i-storbritannia/ 2024-10-23T08:13:10+00:00 https://www.lmi.no/2024/10/23/nar-finner-vi-kuren-for-kreft/ 2024-10-23T08:14:14+00:00 https://www.lmi.no/2024/10/23/nyfodtscreeningen-ved-ous-utvides-og-inviterer-til-samarbeid/ 2024-10-23T10:07:22+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Nyfodtscreeningen-10_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/Nyfodtscreeningen-10_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4361-BLUR-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4354-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4342-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4340-BLUR-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4336-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4325-BLUR-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4364-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/IMG_4323-scaled.jpg https://www.lmi.no/2024/10/24/nho-geneo-inviterer-til-statusmote-om-ventetidsloftet/ 2024-10-24T08:45:02+00:00 https://www.lmi.no/wp-content/uploads/2024/08/ventetidsloftet-forste-mote-kopi-1.jpg https://www.lmi.no/wp-content/uploads/2024/08/ventetidsloftet-forste-mote-kopi-1.jpg https://www.lmi.no/2024/10/24/venstre-onsker-oppstramming-i-dmp/ 2024-10-24T08:48:40+00:00 https://www.lmi.no/2024/10/24/calluna-pharma-har-fullfort-fase-1-oppmuntrende-funn/ 2024-10-24T08:49:33+00:00 https://www.lmi.no/2024/10/24/elena-hadde-alvorleg-atopisk-eksem-i-fire-ar-ny-medisin-fungerte-etter-fire-veker/ 2024-10-24T08:54:20+00:00 https://www.lmi.no/2024/10/24/haper-dmp-laerer/ 2024-10-24T08:55:34+00:00 https://www.lmi.no/2024/10/24/amerikanske-legemiddelmyndigheter-godkjenner-pfizers-rsv-vaksine-til-ny-pasientgruppe/ 2024-10-24T08:56:26+00:00 https://www.lmi.no/2024/10/25/storbritannia-alzheimermedisinen-donanemab-er-ikke-kostnadseffektiv/ 2024-10-25T07:57:07+00:00 https://www.lmi.no/2024/10/25/eli-lilly-lanserer-fedmemedisin-i-norge-om-kort-tid/ 2024-10-25T09:31:25+00:00 https://www.lmi.no/2024/10/25/dyr-sma-medisin-vurderes-pa-ny-noen-voksne-pasienter-star-uten-et-behandlingstilbud/ 2024-10-25T09:32:34+00:00 https://www.lmi.no/2024/10/25/da-produsentene-selv-betalte-for-studien-virket-medisinen-plutselig-bedre/ 2024-10-25T10:39:48+00:00 https://www.lmi.no/2024/10/25/informerte-ikke-om-hoy-risiko-i-alzheimer-studier/ 2024-10-25T10:41:43+00:00 https://www.lmi.no/2024/10/25/krafttak-for-legemiddelproduksjon-i-kragero/ 2024-10-25T10:46:30+00:00 https://www.lmi.no/wp-content/uploads/2024/10/20241023_130814-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/20241023_130814-scaled.jpg https://www.lmi.no/2024/10/28/gsk-investerer-875-milliarder-kroner-i-nytt-produksjonsanlegg/ 2024-10-28T07:44:59+00:00 https://www.lmi.no/2024/10/28/ruster-seg-for-fedmelansering-har-okt-antall-ansatte-i-norge-med-38-prosent/ 2024-10-28T07:46:06+00:00 https://www.lmi.no/2024/10/28/calluna-pharma-vil-starte-fase-2-studie-pa-behandling-mot-lungefibrose-i-2025/ 2024-10-28T07:47:12+00:00 https://www.lmi.no/2024/10/28/debatt-oslo-er-langt-fra-bare-en-administrasjonsby-vedum/ 2024-10-28T07:48:13+00:00 https://www.lmi.no/2024/10/28/en-kinesisk-mann-med-systemisk-sklerose-ble-en-av-de-forste-i-verden-til-a-fa-en-ny-type-immunterapi/ 2024-10-28T07:49:27+00:00 https://www.lmi.no/2024/10/28/drikker-du-dette-kan-det-tilsvare-en-lopetur-pa-en-mil/ 2024-10-28T07:51:03+00:00 https://www.lmi.no/2024/10/28/tipper-at-beslutningsforum-puster-lettet-ut-etter-den-beslutningen/ 2024-10-28T07:52:25+00:00 https://www.lmi.no/2024/10/28/kvinnehelsesatsningen-trenger-kvinnelige-ledere/ 2024-10-28T08:17:51+00:00 https://www.lmi.no/2024/10/28/eli-lilly-har-fatt-hong-kong-godkjennelse-for-fedmemedisin/ 2024-10-28T08:18:44+00:00 https://www.lmi.no/2024/10/28/flere-titalls-tusen-kjoper-fedmemedisiner-ikke-alle-har-rad/ 2024-10-28T08:19:36+00:00 https://www.lmi.no/2024/10/28/helsedata-soknader-det-enkle-er-ofte-det-beste/ 2024-10-28T11:07:20+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Helsedataservice-og-industrien-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/Helsedataservice-og-industrien-scaled.jpg https://www.lmi.no/2024/10/29/na-starter-slankekonkurransen-for-alvor-i-norge/ 2024-10-29T07:01:11+00:00 https://www.lmi.no/2024/10/29/en-glipp-fra-sykehusinnkjop-kan-ha-gitt-betydelige-tap-for-legemiddelselskaper/ 2024-10-29T07:03:08+00:00 https://www.lmi.no/2024/10/29/industrien-reagerer-pa-feil-i-anbud-overraskende-og-bekymringsfullt/ 2024-10-29T07:07:32+00:00 https://www.lmi.no/2024/10/29/debatt-de-arlige-rs-virusepidemiene-blant-spedbarn-kan-unngas-hvis-myndighetene-vil/ 2024-10-29T07:10:20+00:00 https://www.lmi.no/2024/10/29/reagerer-pa-slankenyhet-kan-ikke-vaere-lommeboka-som-avgjor/ 2024-10-29T07:12:45+00:00 https://www.lmi.no/2024/10/29/dobling-i-bruken-av-adhd-medisin-siden-2019/ 2024-10-29T07:13:37+00:00 https://www.lmi.no/2024/10/29/kutt-og-head-count-preger-helsenaeringen-pharma-relations-opplever-vekst-i-innleie/ 2024-10-29T07:15:15+00:00 https://www.lmi.no/2024/10/29/analytikere-frykter-skuffende-kvartalsresultater-for-novo-nordisk/ 2024-10-29T07:17:03+00:00 https://www.lmi.no/2024/10/29/msds-antistoffbehandling-reduserte-forekomsten-av-rsv-sykdom-hos-spedbarn-i-studie/ 2024-10-29T07:18:05+00:00 https://www.lmi.no/2024/10/29/nykode-i-mal-med-oppsigelsesrunde-en-vanskelig-balanse/ 2024-10-29T07:19:21+00:00 https://www.lmi.no/2024/10/29/disse-poliklinikkene-for-hjertesvikt-er-best-og-darligst-i-landet/ 2024-10-29T08:11:26+00:00 https://www.lmi.no/2024/10/23/forelopig-program-for-frokostmote-om-blareseptanbud/ 2024-10-29T12:41:40+00:00 https://www.lmi.no/wp-content/uploads/2024/10/blaresept-1.jpg https://www.lmi.no/wp-content/uploads/2024/10/blaresept.jpg https://www.lmi.no/2024/11/01/nordic-life-science-days-2025/ 2024-11-01T09:00:00+00:00 https://www.lmi.no/wp-content/uploads/2024/10/NLSD24-Design-2_1200x627px.png https://www.lmi.no/wp-content/uploads/2024/10/NLSD24-Design-1_1200x627px.png https://www.lmi.no/2024/10/30/forste-mote-i-topplederforum-for-helsenaeringen/ 2024-10-30T10:55:58+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Topplederforum-for-helsenaeringen-2024-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/Topplederforum-for-helsenaeringen-2024-scaled.jpeg https://www.lmi.no/2024/10/30/pfizer-stiger-kraftig-etter-oppjusterte-forventninger-og-et-sterkt-tredje-kvartal/ 2024-10-30T11:09:19+00:00 https://www.lmi.no/2024/10/30/stortingspolitikere-med-hpv-krav-til-helseministeren-na-blir-det-debatt/ 2024-10-30T11:10:44+00:00 https://www.lmi.no/2024/10/30/europa-rammes-av-infusjonsvaeskemangel-som-folge-av-orkanen-helene/ 2024-10-30T11:11:55+00:00 https://www.lmi.no/2024/10/30/mounjaro-blir-dyrere-enn-wegovy-forventer-likevel-stor-ettersporsel/ 2024-10-30T11:12:59+00:00 https://www.lmi.no/2024/10/30/abbvie-kjoper-alzheimersselskap/ 2024-10-30T11:14:01+00:00 https://www.lmi.no/2024/10/31/eus-innstilte-helsekommisaer-vil-styrke-innovasjon-og-cybersikkerheten-i-europeisk-helseindustri/ 2024-10-31T11:03:37+00:00 https://www.lmi.no/2024/10/31/norske-rallybio-klar-for-fase-2-studie-i-norge-og-europa/ 2024-10-31T11:04:32+00:00 https://www.lmi.no/2024/10/31/vil-bruke-slankesproyter-for-a-fa-folk-i-arbeid/ 2024-10-31T11:05:25+00:00 https://www.lmi.no/2024/10/31/eisai-tjente-715-millioner-kroner-pa-salg-av-alzheimerlegemiddel-i-tredje-kvartal/ 2024-10-31T11:06:27+00:00 https://www.lmi.no/2024/10/31/astrazenecas-kina-direktor-er-under-etterforskning/ 2024-10-31T11:08:43+00:00 https://www.lmi.no/2024/10/31/klimaendringene-far-fransk-vaksineprodusent-til-a-utvide-til-det-nordiske-markedet/ 2024-10-31T11:09:49+00:00 https://www.lmi.no/2024/10/31/gsk-leverer-over-forventningene-vaksineinntekter-skuffer/ 2024-10-31T11:10:45+00:00 https://www.lmi.no/2024/10/31/avlyser-priskrig-pa-slankemedisin-vi-jobber-ikke-for-a-slass-med-novo-nordisk/ 2024-10-31T11:11:47+00:00 https://www.lmi.no/2024/10/31/novo-nordisk-og-astrazeneca-er-nordens-to-storste-selskaper/ 2024-10-31T11:12:50+00:00 https://www.lmi.no/2024/10/31/eli-lilly-skuffer-med-salgstall-for-tredje-kvartal/ 2024-10-31T11:13:45+00:00 https://www.lmi.no/2024/11/01/norge-med-ny-who-strategi/ 2024-11-01T08:45:34+00:00 https://www.lmi.no/wp-content/uploads/2024/11/LeifIFPMAcrop-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/LeifIFPMAcrop-scaled.jpg https://www.lmi.no/2024/11/01/boehringer-ingelheim-stanser-utviklingen-av-danske-gubras-fedmemedisin/ 2024-11-01T10:09:53+00:00 https://www.lmi.no/2024/11/01/rekordhoy-produksjon-for-vistin-pharma/ 2024-11-01T10:10:52+00:00 https://www.lmi.no/2024/11/01/johnson-johnson-vant-anbud-slo-generisk-konkurranse/ 2024-11-01T10:27:29+00:00 https://www.lmi.no/2024/11/01/na-lanseres-den-nye-fedmemedisinen-mounjaro-dette-mener-fagfolkene/ 2024-11-01T10:28:52+00:00 https://www.lmi.no/2024/11/01/sykehusinnkjop-boter-pa-feil-forlenger-tnf-bio-anbudet-med-tre-maneder/ 2024-11-01T10:36:47+00:00 https://www.lmi.no/2024/11/01/infusjonsvaeske-produsent-i-gang-igjen-etter-orkan-stans/ 2024-11-01T10:37:44+00:00 https://www.lmi.no/2024/11/01/ruller-ut-rod-loper-til-produksjonsselskaper/ 2024-11-01T12:02:46+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Legemiddelproduksjon_1600x900.jpg https://www.lmi.no/wp-content/uploads/2024/11/Legemiddelproduksjon_1600x900.jpg https://www.lmi.no/2024/10/29/frokostmote-om-prioriteringsmeldingen/ 2024-11-01T12:32:19+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Banner_Frokostmote-prioriteringer-2024-e1730922892705.jpg https://www.lmi.no/wp-content/uploads/2024/10/Banner_Frokostmote-prioriteringer-2024-e1730922892705.jpg https://www.lmi.no/2024/11/01/dmp-nyheter-pa-regulatorisk-hostmote/ 2024-11-01T12:37:26+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Regmote24_LinnCamilla_Audun_salen2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Regmote24_LinnCamilla_Audun_Salen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Anne-Margrethe-Hausken-Nordberg-digital-scan-oakkningsvedlegg-felleskatalogen-6153-scaled.jpg https://www.lmi.no/2024/11/04/lmi-onsker-partnere-til-arendalsuka-2025/ 2024-11-04T10:00:00+00:00 https://www.lmi.no/wp-content/uploads/2024/11/LMI-Venterommet-53-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/LMI-Venterommet-62-scaled.jpg https://www.lmi.no/2024/11/04/fedmelege-advarer-til-tross-for-ny-konkurranse-slankemedisiner-kan-skape-klasseskille/ 2024-11-04T08:11:01+00:00 https://www.lmi.no/2024/11/04/lmi-direktoren-oppfordrer-regjeringen-til-a-se-til-ny-dansk-life-science-strategi-norge-er-lillesosteren/ 2024-11-04T08:21:06+00:00 https://www.lmi.no/2024/11/04/nordmenn-sparer-tusenvis-pa-a-kjope-slankemedisiner-i-sverige/ 2024-11-04T08:22:22+00:00 https://www.lmi.no/2024/11/04/slankemedisiner-til-barn-%e2%81%a0-bor-fa-tilbud/ 2024-11-04T08:24:06+00:00 https://www.lmi.no/2024/11/04/danmarks-regjering-presenterer-en-strategi-med-31-tiltakspunkter-for-a-styrke-life-science-sektoren/ 2024-11-04T08:25:51+00:00 https://www.lmi.no/2024/11/04/har-fatt-millioner-til-a-bruke-fisk-i-revolusjonaer-kreftforskning/ 2024-11-04T08:28:47+00:00 https://www.lmi.no/2024/09/03/bekeng-til-strategisamlingen/ 2024-11-05T10:52:56+00:00 https://www.lmi.no/wp-content/uploads/2024/09/kkb-09-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/kkb-09-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/09/71960a459480f7c4a8457688ab72fbb92c0fc896-2000x2831-1.jpg https://www.lmi.no/wp-content/uploads/2024/09/IdarKreutzer-102-2.jpg https://www.lmi.no/2024/11/05/blir-direktor-for-novo-nordisk-i-norge/ 2024-11-05T12:46:17+00:00 https://www.lmi.no/2024/11/05/msd-kritisk-til-pris-vektlegging-i-vaksineanbud/ 2024-11-05T12:47:15+00:00 https://www.lmi.no/2024/11/05/legemiddel-gikk-av-patent-vant-likevel-anbudskonkurranse/ 2024-11-05T12:48:23+00:00 https://www.lmi.no/2024/11/05/han-er-ny-medisinsk-direktor-i-amgen-norge-vi-har-unike-muligheter-til-a-utnytte-dataene-vare-enda-bedre/ 2024-11-05T12:49:56+00:00 https://www.lmi.no/2024/11/05/den-nye-dmp-direktoren-er-utalmodig-vi-er-ikke-der-vi-skal-vaere/ 2024-11-05T12:51:21+00:00 https://www.lmi.no/2024/11/05/kreftsjuke-cecilie-hadde-kort-tid-igjen-11-ar-etter-lever-ho-eit-godt-liv/ 2024-11-05T12:52:16+00:00 https://www.lmi.no/2024/11/05/oncoinvent-har-fatt-studie-publisert-noterer-seg-ingen-alvorlige-hendelser/ 2024-11-05T12:53:48+00:00 https://www.lmi.no/2024/11/05/tnf-bio-anbudet-for-lettvint-a-kalle-dette-en-glipp/ 2024-11-05T12:54:51+00:00 https://www.lmi.no/2024/11/05/eu-innleder-etterforskning-av-novo-holdings-oppkjop-av-catalent/ 2024-11-05T12:56:02+00:00 https://www.lmi.no/2024/11/05/dette-er-vinnerne-av-norges-storste-legemiddelanbud/ 2024-11-05T12:56:54+00:00 https://www.lmi.no/2024/11/06/dmp-prioriterer-ikke-flere-anbud-i-blareseptordningen-na/ 2024-11-06T11:20:13+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Frokostmote-om-anbud-i-Blareseptordningen.jpg https://www.lmi.no/wp-content/uploads/2024/11/Frokostmote-om-anbud-i-Blareseptordningen.jpg https://www.lmi.no/2024/11/06/anbud-pa-blaresept-legg-til-rette-for-fastlegene-vi-kan-ikke-bruke-tid-pa-byrakrati/ 2024-11-06T11:22:05+00:00 https://www.lmi.no/2024/11/06/photocure-partner-far-markedsforingstillatelse-for-legemiddel-i-kina/ 2024-11-06T11:23:05+00:00 https://www.lmi.no/2024/11/06/lytix-styremedlem-blir-direktor-for-selskapets-amerikanske-lisenspartner/ 2024-11-06T11:26:49+00:00 https://www.lmi.no/2024/11/06/novo-nordisk-i-tredje-kvartal-omsetning-noe-lavere-enn-forventet-resultat-noe-bedre/ 2024-11-06T11:27:33+00:00 https://www.lmi.no/2024/11/06/brystkreft-medisin-doblet-tiden-for-tilbakefall-kan-bli-den-nye-standardbehandlingen/ 2024-11-06T11:28:21+00:00 https://www.lmi.no/2024/11/06/livsvitenskapskonferansen-2025/ 2024-11-06T13:07:44+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Banner_Kvadratisk_1080x1080_Norsk.png https://www.lmi.no/wp-content/uploads/2024/11/Banner_Artikkel_1000x563_Norsk.png https://www.lmi.no/2024/11/04/novo-nordisk-ansetter-ny-daglig-leder-i-norge/ 2024-11-08T06:47:44+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Whitfield_NN_MG_9019-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Whitfield_NN_MG_9019-scaled.jpg https://www.lmi.no/2024/11/08/arcticzymes-med-lavere-omsetning-melder-om-vekst-for-bioproduksjon/ 2024-11-08T10:00:23+00:00 https://www.lmi.no/2024/11/08/ingen-nye-blareseptanbud-for-godt-ut-i-neste-ar/ 2024-11-08T10:03:56+00:00 https://www.lmi.no/2024/11/08/enorm-studie-avslorer-ukjent-arsak-til-utbredt-giktsykdom/ 2024-11-08T10:36:34+00:00 https://www.lmi.no/2024/11/08/prover-pa-ny-godkjenning-av-millionbehandling/ 2024-11-08T10:38:21+00:00 https://www.lmi.no/2024/11/08/johnson-johnson-inngar-avtale-med-nasjonal-presisjonsmedisin-studie/ 2024-11-08T10:39:20+00:00 https://www.lmi.no/2024/11/08/car-t-blir-snart-landsdekkende-et-paradigmeskifte/ 2024-11-08T10:40:43+00:00 https://www.lmi.no/2024/11/08/miljovennlige-anbud-kofa-godkjenner-sykehusinnkjops-bruk-av-minstekrav-i-stedet-for-tildelingskriterium/ 2024-11-08T10:41:45+00:00 https://www.lmi.no/2024/11/08/dmp-avviser-ikke-blaresept-anbud-for-glp-1-medisiner/ 2024-11-08T10:43:10+00:00 https://www.lmi.no/2024/11/08/nye-blareseptanbud-forskyves-lmi-mener-direktoratet-prioriterer-riktig/ 2024-11-08T10:44:36+00:00 https://www.lmi.no/2024/11/08/uforutsett-legemiddelkostnad-til-en-pasient-sprenger-budsjettet/ 2024-11-08T10:45:50+00:00 https://www.lmi.no/2024/11/08/begraver-blodtrykkskandidat/ 2024-11-08T10:46:56+00:00 https://www.lmi.no/2024/11/08/uenig-i-avslag-pa-lungemedisin-i-beslutningsforum/ 2024-11-08T10:47:59+00:00 https://www.lmi.no/2024/11/08/moderna-tjener-penger-pa-tidlig-godkjenning-av-koronavaksine/ 2024-11-08T10:48:56+00:00 https://www.lmi.no/2024/10/09/lovende-resultater-for-ge-healthcares-fase-i-studie/ 2024-11-11T10:31:07+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Cathrine-Thomassen.jpg https://www.lmi.no/wp-content/uploads/2022/11/Cathrine-Thomassen.jpg https://www.lmi.no/2024/11/11/lokale-medier-pfizer-vil-investere-over-en-milliard-dollar-i-kina-de-neste-fem-arene/ 2024-11-11T10:44:31+00:00 https://www.lmi.no/2024/11/11/nykode-kollapset-etter-avtaletap/ 2024-11-11T10:46:18+00:00 https://www.lmi.no/2024/11/11/sykehusinnkjop-unngar-a-svare-pa-kritikk-om-kreftanbudet/ 2024-11-11T10:47:32+00:00 https://www.lmi.no/2024/11/11/hun-blir-konstituert-som-direktor-i-helsedirektoratet/ 2024-11-11T10:53:25+00:00 https://www.lmi.no/2024/11/11/nykode-mener-avgjorelsen-om-a-avbryte-samarbeid-kom-fra-hoyt-oppe-i-roche/ 2024-11-11T10:54:40+00:00 https://www.lmi.no/2024/11/11/dnb-analytiker-ikke-overrasket-over-at-nykodes-genentech-avtale-royk/ 2024-11-11T10:55:43+00:00 https://www.lmi.no/2024/11/11/krev-politisk-debatt-om-livmorhalsvaksine/ 2024-11-11T10:57:02+00:00 https://www.lmi.no/2024/11/11/blir-slankesproyter-den-nye-normalen/ 2024-11-11T10:59:16+00:00 https://www.lmi.no/2024/11/11/medisin-mot-migrene-hjelpte-mot-endometriose-i-mus/ 2024-11-11T11:00:24+00:00 https://www.lmi.no/2024/11/11/hva-blir-trumps-helsepolitikk-vil-han-kopiere-den-norske-prismodellen-for-legemidler/ 2024-11-11T11:03:10+00:00 https://www.lmi.no/2024/11/11/refusjonsregler-for-effektive-legemidler-blir-en-catch-22-situasjon/ 2024-11-11T11:05:15+00:00 https://www.lmi.no/2024/11/08/danmarks-ambassade-i-oslo-inviterte-til-hjernehelse-kveld/ 2024-11-11T12:21:31+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Lundbeck-og-Danske-ambassaden-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Lundbeck-og-Danske-ambassaden-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Panelet-pa-lundbecks-ambassademote-scaled.jpg https://www.lmi.no/2024/11/11/ge-healthcare-i-oslo-fyller-150-ar/ 2024-11-11T13:29:25+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Kevin-og-Cathrine-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/Kevin-og-Cathrine-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/Kevin-intervju-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/Idar-kopi-1.jpg https://www.lmi.no/wp-content/uploads/2024/11/Kevin-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/PM-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/LR-kopi-1.jpg https://www.lmi.no/2024/11/12/27-forskere-far-milliontildeling-fra-kreftforeningen/ 2024-11-12T10:50:38+00:00 https://www.lmi.no/2024/11/12/norges-storste-farmasoytiske-selskap-fyller-150-ar-dere-har-utviklet-en-fantastisk-arv-i-norge/ 2024-11-12T10:51:31+00:00 https://www.lmi.no/2024/11/12/legen-er-krystallklar-vil-ikke-vaksinere-barna-sine-med-denne-vaksinen/ 2024-11-12T10:52:18+00:00 https://www.lmi.no/2024/11/12/sanofi-jakter-pa-kols-godkjenning-eksperter-strides-om-antall-pasienter/ 2024-11-12T10:53:34+00:00 https://www.lmi.no/2024/11/13/ny-rapport-europa-sakker-akterut/ 2024-11-13T06:00:00+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-2024-11-12-132919-e1731414663544.png https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-2024-11-12-132919-e1731414663544.png https://www.lmi.no/2024/11/13/helsepersonell-vil-ha-slutt-pa-legemiddelhandel-med-israelsk-firma/ 2024-11-13T09:28:57+00:00 https://www.lmi.no/2024/11/13/astrazeneca-oppjusterer-forventingene/ 2024-11-13T11:24:02+00:00 https://www.lmi.no/2024/11/13/bergenbio-begraver-legemiddelkandidat/ 2024-11-13T11:24:54+00:00 https://www.lmi.no/2024/11/13/motte-politisk-ledelse-i-nfd/ 2024-11-13T12:07:16+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Mote-NFD-Skymoen-Thomassen-og-Larsen.jpg https://www.lmi.no/wp-content/uploads/2024/11/Mote-NFD_Skymoen-Thomassen-og-Larsen.jpg https://www.lmi.no/2024/11/14/regjeringa-vurderer-a-innfore-ny-hpv-vaksine/ 2024-11-14T08:58:04+00:00 https://www.lmi.no/2024/11/14/photocures-driftsresultat-har-mer-enn-tredoblet-seg-sa-langt-i-ar/ 2024-11-14T08:59:19+00:00 https://www.lmi.no/2024/11/14/tar-et-oppgjor-med-industrien-for-han-takker-for-seg-et-sted-ma-grensen-ga/ 2024-11-14T09:00:12+00:00 https://www.lmi.no/2024/11/14/malrettet-cellegift-kan-revolusjonere-kreftbehandlingen-slik-fungerer-teknologien/ 2024-11-14T09:01:08+00:00 https://www.lmi.no/2024/11/14/fire-kreftlegemidler-skal-vurderes-i-beslutningsforums-november-mote/ 2024-11-14T09:01:55+00:00 https://www.lmi.no/2024/11/14/presentasjoner-fra-regulatorisk-hostmote-2024/ 2024-11-14T13:31:31+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Regmote24_LinnCamilla_Audun_Salen-1-1280x633-1.jpg https://www.lmi.no/wp-content/uploads/2024/11/Regmote24_LinnCamilla_Audun_Salen-1-scaled.jpg https://www.lmi.no/2024/11/15/artbio-inngar-lisens-og-forskningsavtale-med-tysk-bioteknologiselskap/ 2024-11-15T10:29:23+00:00 https://www.lmi.no/2024/11/15/eus-legemiddelbyra-har-godkjent-alzheimer-medisin/ 2024-11-15T10:31:34+00:00 https://www.lmi.no/2024/11/15/bioarctics-direktor-i-norge-bade-lettet-og-glad/ 2024-11-15T10:32:38+00:00 https://www.lmi.no/2024/11/15/studie-viser-at-eli-lillys-fedmekandidat-holder-99-prosent-diabetesfrie-etter-176-uker/ 2024-11-15T10:33:27+00:00 https://www.lmi.no/2024/11/15/eu-kommisjonen-ma-svare-for-sjefens-vaksinetekstmeldinger-til-pfizer/ 2024-11-15T10:34:34+00:00 https://www.lmi.no/2024/11/15/kreftforeningen-ber-om-stans-av-anbudsprosessen-for-hpv-vaksine/ 2024-11-15T10:35:29+00:00 https://www.lmi.no/2024/11/15/hpv-vaksineanbud-utsatt-med-fire-uker/ 2024-11-15T10:36:21+00:00 https://www.lmi.no/2024/11/17/rfk-jr-vil-rense-opp-i-fda-og-gjor-seg-klar-til-konflikt-med-big-pharma/ 2024-11-17T21:40:28+00:00 https://www.lmi.no/2024/11/17/endringer-i-rasjoneringen-av-ozempic-pasienter-kan-fa-lengre-utlevering/ 2024-11-17T21:43:44+00:00 https://www.lmi.no/2024/11/17/tre-av-fire-voksne-amerikanere-har-overvekt-eller-fedme/ 2024-11-17T21:44:50+00:00 https://www.lmi.no/2024/11/17/ludvig-6-matte-ha-tolv-sproyter-i-dognet-sa-endret-alt-seg/ 2024-11-17T21:46:31+00:00 https://www.lmi.no/2024/11/17/chmp-anbefaler-atte-nye-legemidler-i-november/ 2024-11-17T21:47:28+00:00 https://www.lmi.no/2024/11/17/vi-ma-tenke-nytt-om-finansiering-av-avanserte-legemidler/ 2024-11-17T21:48:39+00:00 https://www.lmi.no/2024/11/17/vaksineselskaper-moter-motstand-pa-borsen-etter-kennedy-ansettelse/ 2024-11-17T21:49:35+00:00 https://www.lmi.no/2024/11/17/vi-kan-ha-fatt-en-ny-medisin-for-nesten-alt-er-det-for-godt-til-a-vaere-sant/ 2024-11-17T21:51:02+00:00 https://www.lmi.no/2024/11/17/nesespray-kan-forsinke-alzheimer-med-over-ti-ar/ 2024-11-17T21:51:56+00:00 https://www.lmi.no/2024/11/17/barn-er-ikke-sma-voksne/ 2024-11-17T22:01:31+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde_17-11-2024_225927_www.nortrials.no_.jpeg https://www.lmi.no/wp-content/uploads/2024/11/c4c-nettverksmote-amsterdam-salen.webp https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde_17-11-2024_225927_www.nortrials.no_.jpeg https://www.lmi.no/2024/11/18/myelomatose-medisin-danket-ut-standardbehandling-overgikk-alle-forventninger/ 2024-11-18T09:12:13+00:00 https://www.lmi.no/2024/11/14/nomvec-soker-ny-daglig-leder/ 2024-11-18T15:04:28+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Logo-nomvec-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/Logo_bla_RGB.png https://www.lmi.no/2024/11/19/ikke-kast-ubrukt-antibiotika-lever-det-til-apoteket/ 2024-11-19T14:33:05+00:00 https://www.lmi.no/2024/11/19/i-norge-fylles-sykehusene-opp-disse-landene-har-fatt-bukt-med-rs-viruset/ 2024-11-19T14:34:08+00:00 https://www.lmi.no/2024/11/19/behandling-av-tre-pasienter-har-kostet-sykehuset-45-millioner-kroner/ 2024-11-19T14:35:58+00:00 https://www.lmi.no/2024/11/19/ny-medisin-testet-pa-200-000-alkoholavhengige-svensker/ 2024-11-19T14:37:30+00:00 https://www.lmi.no/2024/11/19/fedmeepidemien-i-usa-vokser-frem-mot-2050/ 2024-11-19T14:38:23+00:00 https://www.lmi.no/2024/11/19/sv-har-stilt-helseministeren-sporsmal-om-legemiddelhandel-med-israelsk-leverandor/ 2024-11-19T14:39:18+00:00 https://www.lmi.no/2024/11/19/var-avhengig-av-nesespray-jeg-har-provd-alt/ 2024-11-19T14:40:54+00:00 https://www.lmi.no/2024/11/19/trygve-ottersen-har-tiltradt-som-direktor-i-dmp/ 2024-11-19T14:43:18+00:00 https://www.lmi.no/2024/11/19/novo-nordisk-lanserer-wegovy-i-kina-til-en-brokdel-av-prisen-i-usa/ 2024-11-19T14:44:05+00:00 https://www.lmi.no/2024/11/19/beslutningsforum-sa-ja-til-alle-behandlingene/ 2024-11-19T14:45:12+00:00 https://www.lmi.no/2024/11/20/debatt-dagens-terskelverdi-gir-feilprioriteringer/ 2024-11-20T10:32:26+00:00 https://www.lmi.no/wp-content/uploads/2024/11/MedW.png https://www.lmi.no/2024/11/20/advarer-gravide-medisin-kan-fore-til-alvorlige-fosterskader/ 2024-11-20T10:44:47+00:00 https://www.lmi.no/2024/11/20/blir-kalt-et-gedigent-gjennombrudd-mener-norge-ma-punge-ut/ 2024-11-20T10:45:33+00:00 https://www.lmi.no/2024/11/20/christen-sveaas-blir-storste-eier-i-navamedic/ 2024-11-20T10:46:21+00:00 https://www.lmi.no/2024/11/20/antibiotikaresistens-alle-monner-drar/ 2024-11-20T11:33:39+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Antibiotikaresistens-KI-generert-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/11/Antibiotikaresistens-KI-generert-scaled.jpeg https://www.lmi.no/2024/11/20/programmet-for-frokostmote-om-prioriteringsmeldingen-er-klart/ 2024-11-20T12:44:35+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Banner_Frokostmote-prioriteringer-2024-e1730922892705.jpg https://www.lmi.no/wp-content/uploads/2024/10/Banner_Frokostmote-prioriteringer-2024-e1730922892705.jpg https://www.lmi.no/2024/11/21/olav-hellebo-er-ny-bergenbio-direktor/ 2024-11-21T10:16:32+00:00 https://www.lmi.no/2024/11/21/kutter-ut-diabetesmedisin-hjerteskjaerende-at-det-er-profitt-som-betyr-mest/ 2024-11-21T10:17:31+00:00 https://www.lmi.no/2024/11/21/abbvie-far-eu-godkjennelse-for-eggstokkreft-behandling/ 2024-11-21T10:18:47+00:00 https://www.lmi.no/2024/11/21/eu-parlamentet-har-godkjent-kontroversiell-ungarer-som-ny-helsekommisaer/ 2024-11-21T10:19:42+00:00 https://www.lmi.no/2024/11/21/kikhoste-epidemien-kunne-vaert-unngatt-med-enkle-grep/ 2024-11-21T11:13:24+00:00 https://www.lmi.no/2024/11/22/norske-onkologer-om-kreftanbudet-milliardbelop-som-frigjores/ 2024-11-22T08:12:13+00:00 https://www.lmi.no/2024/11/22/strupet-tilgangen-helt-vanvittig/ 2024-11-22T08:14:07+00:00 https://www.lmi.no/2024/11/22/valg-av-hpv-vaksine-bor-vaere-forskningsbasert/ 2024-11-22T08:16:36+00:00 https://www.lmi.no/2024/11/22/ny-faggruppe-for-presisjonsmedisin-ma-mote-fremtidens-behov/ 2024-11-22T08:18:34+00:00 https://www.lmi.no/2024/11/22/oncoinvent-planlegger-100-millioners-emisjon-for-jul/ 2024-11-22T08:19:52+00:00 https://www.lmi.no/2024/11/22/norske-biotekselskaper-snuser-pa-innovasjonsopphold-hos-astrazeneca-i-sverige/ 2024-11-22T08:21:19+00:00 https://www.lmi.no/2024/11/22/lungekreftlege-odd-terje-brustugun-trekker-seg-fra-kreftanbudet/ 2024-11-22T08:23:02+00:00 https://www.lmi.no/2024/11/22/europeisk-forskerteam-ledet-av-sigrid-skanland-far-17-millioner-fra-eu/ 2024-11-22T08:24:10+00:00 https://www.lmi.no/2024/11/22/thor-medical-inngar-avtale-med-et-globalt-ledende-farmasoytisk-selskap/ 2024-11-22T08:25:03+00:00 https://www.lmi.no/2024/11/22/rallybio-starter-fase-2-studie-med-ous-forskere/ 2024-11-22T08:31:27+00:00 https://www.lmi.no/2024/11/25/presentasjoner-fra-drug-safety-forum-4-november-2024/ 2024-11-25T10:16:55+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Drug-Safety-Forum-2024-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Drug-Safety-Forum-2024-scaled.jpg https://www.lmi.no/2024/11/25/markerte-10-ar-med-helseomsorg21-strategien/ 2024-11-25T14:43:56+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Store-HO21-markering-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Store-HO21-markering-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Veronika-i-panel-HO21-markering-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Leif-Rune-og-Usman-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Guro-i-panel-HO21-markering-scaled.jpg https://www.lmi.no/2024/11/26/store-uforutsette-legemiddelkostnader-sprenger-sykehusbudsjetter-dette-sier-politikerne/ 2024-11-26T11:32:27+00:00 https://www.lmi.no/2024/11/26/vi-kan-ha-fatt-en-ny-medisin-for-nesten-alt-er-det-for-godt-til-a-vaere-sant-2/ 2024-11-26T11:39:48+00:00 https://www.lmi.no/2024/11/26/oliver-15-ble-frisk-fra-lymfekreft-pa-ti-dager-det-var-som-en-penicillinkur/ 2024-11-26T11:40:34+00:00 https://www.lmi.no/2024/11/26/digitalt-medlemsmote-6-desember/ 2024-11-26T12:10:11+00:00 https://www.lmi.no/wp-content/uploads/2024/11/front-medlemsmote-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/Medlemsmotet-1810-1280x678-1.png https://www.lmi.no/2024/11/26/arets-hederspris-til-pharmaq/ 2024-11-26T12:23:06+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Pharm-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/hoved.png https://www.lmi.no/2024/11/26/viste-til-naboland-under-dnb-konferansen/ 2024-11-26T16:58:50+00:00 https://www.lmi.no/wp-content/uploads/2024/11/IMG_4096-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/IMG_4095-scaled.jpg https://www.lmi.no/2024/11/26/lmi-har-levert-innspill-til-tildelingsbrev-og-oppdragsdokument-for-2025/ 2024-11-26T20:13:47+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-2024-11-26-205226-edited.png https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-2024-11-26-205226-edited.png https://www.lmi.no/2024/11/27/skal-norske-pasienter-fa-den-beste-kreftbehandlingen-ma-politikerne-vakne/ 2024-11-27T10:48:48+00:00 https://www.lmi.no/2024/11/27/prioriteringsmeldingen-vil-gjelde-for-hele-helsetjenesten-ikke-bare-for-medisinkjop/ 2024-11-27T10:50:43+00:00 https://www.lmi.no/2024/11/27/hod-kom-med-to-debatt-oppfordringer-til-industrien-i-mote-om-prioriteringsmeldingen/ 2024-11-27T10:51:58+00:00 https://www.lmi.no/2024/11/27/kan-totaloverlevelse-erstattes-som-mal-i-kliniske-studier-ny-rapport-gir-svar/ 2024-11-27T10:54:28+00:00 https://www.lmi.no/2024/11/27/dette-svarer-helseministeren-om-store-uforutsette-legemiddelkostnader/ 2024-11-27T10:57:00+00:00 https://www.lmi.no/2024/11/27/omtrent-50-prosent-av-de-ansatte-i-nykode-kan-miste-jobben/ 2024-11-27T10:58:05+00:00 https://www.lmi.no/2024/11/27/pekte-pa-to-utfordringer-en-ny-prioriteringsmelding-ma-lose/ 2024-11-27T11:35:17+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Frokostmote-priomelding-2024.jpg https://www.lmi.no/wp-content/uploads/2024/11/Frokostmote-priomelding-2024.jpg https://www.lmi.no/2024/11/28/presentations-lmis-strategy-meeting-2024/ 2024-12-02T08:05:37+00:00 https://www.lmi.no/2024/12/02/pasientens-legemiddelliste-bor-ikke-ta-tre-nye-ar-for-en-ny-region-er-i-gang/ 2024-12-02T09:03:31+00:00 https://www.lmi.no/2024/12/02/kamp-om-alzheimer-behandling-to-nye-legemidler-endrer-spillet/ 2024-12-02T09:06:10+00:00 https://www.lmi.no/2024/12/02/novo-nordisks-wegovy-far-hjerteinfarkts-godkjennelse-i-canada/ 2024-12-02T09:08:03+00:00 https://www.lmi.no/2024/12/02/rootwelt-om-ny-rapport-vi-vurderer-allerede-bade-levetid-og-livskvalitet/ 2024-12-02T09:10:07+00:00 https://www.lmi.no/2024/12/02/lundbeck-starter-senfasestudie-for-behandling-av-sjelden-nevrologisk-lidelse/ 2024-12-02T09:11:43+00:00 https://www.lmi.no/2024/12/02/novartis-far-ema-godkjenning-for-brystkreftlegemiddel/ 2024-12-02T09:18:09+00:00 https://www.lmi.no/2024/12/02/dmp-med-atte-vedtak-om-ulovlig-legemiddelreklame/ 2024-12-02T09:21:32+00:00 https://www.lmi.no/2024/12/02/innovasjon-norge-samlet-helseeksportorer-til-landslagssamling-for-a-oke-internasjonal-suksess/ 2024-12-02T09:23:43+00:00 https://www.lmi.no/2024/12/02/ny-ema-plattform-skal-gi-oversikt-over-legemiddelmangel-i-europa/ 2024-12-02T09:24:40+00:00 https://www.lmi.no/2024/12/02/ny-studie-vanlig-hjertemedisin-oker-risikoen-for-depresjon/ 2024-12-02T09:25:29+00:00 https://www.lmi.no/2024/12/02/slik-virker-de-revolusjonerende-slankemedisinene/ 2024-12-02T09:26:47+00:00 https://www.lmi.no/2024/12/02/to-ar-med-car-t-behandling-mot-lymfom-dette-er-overlegenes-erfaring/ 2024-12-02T09:28:09+00:00 https://www.lmi.no/2024/12/02/2022-kullet-uteksaminert-fra-spark-programmet/ 2024-12-02T09:29:02+00:00 https://www.lmi.no/2024/12/02/novo-nordisk-faser-ut-insulinprodukter-her-er-foreningenes-rad-til-leger/ 2024-12-02T09:29:26+00:00 https://www.lmi.no/2024/12/02/svensk-japansk-alzheimerslegemiddel-lansert-i-sor-korea/ 2024-12-02T09:30:22+00:00 https://www.lmi.no/2024/12/02/halden-pharma-eier-kjoper-opp-sveitsisk-produksjonsselskap/ 2024-12-02T09:32:51+00:00 https://www.lmi.no/2024/12/02/godkjenner-ny-behandling-for-tidlig-brystkreft-moter-konkurranse/ 2024-12-02T09:33:46+00:00 https://www.lmi.no/2024/12/02/oncoinvent-skal-pa-oslo-bors-ma-vaere-litt-var-overfor-de-som-legger-mest-penger-pa-bordet/ 2024-12-02T09:34:46+00:00 https://www.lmi.no/2024/12/02/farmasiet-advarer-mot-falske-produkter-pa-black-friday/ 2024-12-02T09:35:36+00:00 https://www.lmi.no/2024/12/02/mye-brukt-astmamedisin-knyttes-til-nevrologiske-bivirkninger/ 2024-12-02T09:36:24+00:00 https://www.lmi.no/2024/12/02/fikk-ikke-sende-paracet-i-posten-anker-til-hoyesterett/ 2024-12-02T09:37:41+00:00 https://www.lmi.no/2024/12/02/eksklusivt-intervju-med-mercks-globale-sjef-norge-ma-handle-na/ 2024-12-02T09:39:16+00:00 https://www.lmi.no/2024/12/02/for-fa-veit-at-dei-er-beinskjore-kostar-samfunnet-milliardar/ 2024-12-02T09:41:32+00:00 https://www.lmi.no/2024/12/02/verdens-aids-dag-med-viktige-paminnelser/ 2024-12-02T11:20:37+00:00 https://www.lmi.no/wp-content/uploads/2024/12/AdobeStock_219093223-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/12/AdobeStock_219093223-scaled.jpeg https://www.lmi.no/2024/12/03/sanofi-skal-investere-116-milliarder-i-insulinproduksjon-i-beijing/ 2024-12-03T10:24:56+00:00 https://www.lmi.no/2024/12/03/advarer-om-legemiddel-risiko-for-fosterskade/ 2024-12-03T10:25:53+00:00 https://www.lmi.no/2024/12/03/novo-nordisk-investerer-milliarder-i-laboratorier-i-hillerod/ 2024-12-03T10:26:40+00:00 https://www.lmi.no/2024/12/03/gar-i-gang-med-fellesnordiske-pakningsvedlegg-fra-nyttar/ 2024-12-03T10:27:35+00:00 https://www.lmi.no/2024/12/03/finanshus-tviler-pa-wegovy-arvtagers-salgsevne/ 2024-12-03T10:28:40+00:00 https://www.lmi.no/2024/12/04/to-store-investeringsfond-setter-penger-i-norske-clexbio/ 2024-12-04T08:45:47+00:00 https://www.lmi.no/2024/12/04/noen-far-andre-ikke-stor-variasjon-i-tilbud-om-parkinson-medisin/ 2024-12-04T08:47:01+00:00 https://www.lmi.no/2024/12/04/studie-over-halvparten-avslutter-statinbehandling-etter-oppstart-med-pcsk9-hemmere/ 2024-12-04T08:48:46+00:00 https://www.lmi.no/2024/12/04/roche-immunterapi-mislykkes-i-lungekreftstudie/ 2024-12-04T08:49:39+00:00 https://www.lmi.no/2024/12/04/lundbeck-nar-endepunkt-i-migrenestudie/ 2024-12-04T08:50:31+00:00 https://www.lmi.no/2024/12/04/ge-healthcare-inngar-strategisk-samarbeid-med-exact-therapeutics/ 2024-12-04T08:51:38+00:00 https://www.lmi.no/2024/12/04/dansk-bioteknologiselskap-henter-over-935-millioner-kroner-til-utvikling-av-ny-fedmemedisin/ 2024-12-04T08:52:37+00:00 https://www.lmi.no/2024/12/04/circio-lanserer-ny-rna-teknologi/ 2024-12-04T08:53:23+00:00 https://www.lmi.no/2024/12/04/horinger-forslag-til-lovendringer-i-helseforsknings-helseregister-helsepersonell-og-pasientjournalloven/ 2024-12-04T12:31:47+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2024/12/04/lmi-til-nettavisen-om-kikhoste-denne-sykdommen-onsker-du-virkelig-ikke/ 2024-12-04T14:02:03+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Hausken-i-Nettavisen.png https://www.lmi.no/wp-content/uploads/2024/12/Nettavisen-kikhoste.png https://www.lmi.no/wp-content/uploads/2023/01/anne-margrethe-crop-2-scaled-e1748933566845.jpg https://www.lmi.no/2024/12/05/oncoinvent-inngar-avtale-med-artbio/ 2024-12-05T08:24:36+00:00 https://www.lmi.no/2024/12/05/norges-mektigste-helsebyrakrat-vi-skal-bygge-en-sterkere-helsenaering-gjennom-offentlig-privat-samarbeid-og-kulturendring/ 2024-12-05T08:26:47+00:00 https://www.lmi.no/2024/12/05/novo-nordisk-kjoper-tsjekkisk-proteinfabrikk/ 2024-12-05T08:29:50+00:00 https://www.lmi.no/2024/12/05/konsulentselskap-skal-utarbeide-rapport-om-doseringsfeil-i-e-resept/ 2024-12-05T08:30:54+00:00 https://www.lmi.no/2024/12/05/anbefaler-kjernejournal-som-nasjonal-kilde-for-legemiddelreaksjoner/ 2024-12-05T08:32:34+00:00 https://www.lmi.no/2024/12/05/astrazeneca-oppnevner-ny-internasjonal-visepresident-samtidig-som-den-forrige-er-under-etterforskning-i-kina/ 2024-12-05T08:33:32+00:00 https://www.lmi.no/2024/12/05/ny-slankesproyte-studie-denne-er-klart-mest-effektiv/ 2024-12-05T08:34:58+00:00 https://www.lmi.no/2024/12/05/sykehusene-blir-staende-alene-med-kostnadene-til-sjeldne-sykdommer/ 2024-12-05T08:37:28+00:00 https://www.lmi.no/2024/12/05/nykode-deler-nye-kreftvaksine-data/ 2024-12-05T08:38:40+00:00 https://www.lmi.no/2024/12/05/oncoinvent-henter-130-millioner-kroner-gjennom-emisjon/ 2024-12-05T08:41:38+00:00 https://www.lmi.no/2024/12/05/tildeling-av-hpv-anbudet-utsatt-igjen/ 2024-12-05T08:42:49+00:00 https://www.lmi.no/2024/12/05/alzheimers-legemiddel-far-godkjennelse-i-mexico/ 2024-12-05T08:43:39+00:00 https://www.lmi.no/2024/12/04/meld-deg-pa-livsvitenskapskonferansen-2025/ 2024-12-05T09:02:45+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Banner_Kvadratisk_1080x1080_Norsk-1.png https://www.lmi.no/wp-content/uploads/2024/12/Banner_Kvadratisk_1080x1080_Norsk-1.png https://www.lmi.no/2024/12/02/lmi-inviterer-til-ki-kurs-for-legemiddelindustrien/ 2024-12-05T12:02:20+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-02-1207277-1.png https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-02-1207277-1.png https://www.lmi.no/2024/12/03/draghi-rapporten-brussels-we-have-a-problem/ 2024-12-05T13:42:32+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-scaled.jpg https://www.lmi.no/2024/12/06/slik-skal-norge-hevde-seg-i-den-internasjonale-konkurransen/ 2024-12-06T13:38:51+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-19_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-14_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-7_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-3_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-15_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Nordic-Horizon-10_foto-Bard-Braende_Plus-AS-scaled.jpg https://www.lmi.no/2024/12/09/medlemsmotet-i-opptak/ 2024-12-09T10:21:06+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Front-medlm-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2medlmote1.png https://www.lmi.no/2024/12/09/bruk-samfunnsperspektiv-i-prioritering-av-helsetjenester/ 2024-12-09T11:00:22+00:00 https://www.lmi.no/2024/12/09/profilert-lege-far-ikke-gi-rad-om-ny-kreftmedisin-plutselig-ble-det-sort-hvitt/ 2024-12-09T11:02:10+00:00 https://www.lmi.no/2024/12/09/svenske-alligator-bioscience-kutter-arbeidsstokken-med-70-prosent/ 2024-12-09T11:03:11+00:00 https://www.lmi.no/2024/12/09/eli-lilly-vil-bruke-over-442-milliarder-kroner-pa-fabrikkutvidelse/ 2024-12-09T11:04:00+00:00 https://www.lmi.no/2024/12/09/kan-bli-en-gamechanger-den-forste-nye-behandlingen-mot-astmaanfall-pa-50-ar/ 2024-12-09T11:05:10+00:00 https://www.lmi.no/2024/12/09/eu-lanserer-betalingsmodell-for-ny-antibiotika/ 2024-12-09T11:08:19+00:00 https://www.lmi.no/2024/12/09/eldre-dropper-koronavaksine/ 2024-12-09T11:11:40+00:00 https://www.lmi.no/2024/12/09/beslutningsforum-skal-ta-stilling-til-14-behandlinger-i-sitt-neste-mote/ 2024-12-09T11:12:43+00:00 https://www.lmi.no/2024/12/09/dugnadsanden-begeistrer-takedas-nye-norden-sjef-jeg-liker-tanken-pa-at-folket-skal-tjene-sitt-samfunn/ 2024-12-09T11:13:34+00:00 https://www.lmi.no/2024/12/09/ge-vingmed-ultrasound-flytter-produksjonen-til-utlandet-100-ansatte-mister-jobben/ 2024-12-09T11:14:27+00:00 https://www.lmi.no/2024/12/09/st-olavs-lege-trekker-seg-fra-metodevurderinger-etter-nye-dmp-krav/ 2024-12-09T11:15:34+00:00 https://www.lmi.no/2024/12/09/ash-2024-nye-gjennombrudd-skaper-fremtidens-behandling-av-blodsykdommer/ 2024-12-09T11:16:35+00:00 https://www.lmi.no/2024/12/09/ny-studie-diabetes-medisin-kan-vaere-effektiv-mot-utbredt-kreftform/ 2024-12-09T11:18:29+00:00 https://www.lmi.no/2024/12/09/mulig-gjennombrudd-i-alzheimers-forskningen-%e2%81%a0-pa-terskelen-til-noe-stort/ 2024-12-09T11:20:58+00:00 https://www.lmi.no/2024/12/09/spadom-etter-sterke-ash-data-kml-blir-snart-var-storste-leukemi-sykdom/ 2024-12-09T11:22:03+00:00 https://www.lmi.no/2024/12/09/antallet-voksne-som-lever-med-diabetes-har-doblet-seg-i-verden-de-siste-30-arene/ 2024-12-09T11:22:57+00:00 https://www.lmi.no/2024/12/09/car-t-er-like-god-i-virkeligheten-som-i-kliniske-studier/ 2024-12-09T11:23:53+00:00 https://www.lmi.no/2024/12/09/drapet-pa-toppsjefen-i-amerikansk-helseforsikringsselskap-en-enorm-vekker/ 2024-12-09T11:25:19+00:00 https://www.lmi.no/2024/12/09/jeg-vil-ikke-gravlegge-sonnen-min-enna/ 2024-12-09T11:26:36+00:00 https://www.lmi.no/2024/12/10/kreftforeningen-om-dmps-avvisning-av-lege-fornuftig/ 2024-12-10T11:17:26+00:00 https://www.lmi.no/2024/12/10/schjesvold-svarer-kreftforeningens-leder-veldig-uenig-i-hennes-tolkning/ 2024-12-10T11:18:20+00:00 https://www.lmi.no/2024/12/10/gjor-comeback-i-benmargskreft-svaert-effektiv-behandling/ 2024-12-10T11:19:42+00:00 https://www.lmi.no/2024/12/10/eldre-pasienter-med-mantelcellelymfom-kan-behandles-uten-cellegift/ 2024-12-10T11:20:38+00:00 https://www.lmi.no/2024/12/10/ny-studie-kan-senke-terskelen-for-behandling-av-ulmende-benmargskreft/ 2024-12-10T11:21:37+00:00 https://www.lmi.no/2024/12/10/nye-studiedata-pa-kll-behandling-overrasker-ahus-overlege/ 2024-12-10T11:22:41+00:00 https://www.lmi.no/2024/12/10/beslutningsforum-godkjenner-ny-behandling-for-tidlig-brystkreft/ 2024-12-10T11:28:20+00:00 https://www.lmi.no/2024/12/10/frida-bugge-askeland-vinner-pris-pa-ash-kongressen-for-andre-ar-pa-rad/ 2024-12-10T11:29:48+00:00 https://www.lmi.no/2024/12/10/ous-leder-om-habilitet-naturlig-at-dmp-gjor-sine-vurderinger/ 2024-12-10T11:30:45+00:00 https://www.lmi.no/2024/12/10/har-betalt-nesten-en-million-for-a-fa-leve-videre/ 2024-12-10T11:33:21+00:00 https://www.lmi.no/2024/12/09/lmi-i-altinget-bruk-samfunnsperspektiv-i-prioritering-av-helsetjenester/ 2024-12-10T12:02:22+00:00 https://www.lmi.no/wp-content/uploads/2024/12/front-AT-kopi-3.jpg https://www.lmi.no/wp-content/uploads/2024/12/front-AT-kopi.jpg https://www.lmi.no/2024/12/10/dagens-medisin-industritopp-bekymret-over-habilitetsvurdering/ 2024-12-10T12:02:27+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-10-124607.png https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-10-124607.png https://www.lmi.no/2024/12/11/parkinson-kandidat-ga-effekt-flere-maneder-etter-avsluttet-studie/ 2024-12-11T11:14:05+00:00 https://www.lmi.no/2024/12/11/fant-1580-antibiotika-resistente-bakterier-i-bergen-kloakken-%e2%81%a0-langt-mer-enn-ventet/ 2024-12-11T11:15:01+00:00 https://www.lmi.no/2024/12/11/synnove-berget-rusten-lever-med-uhelbredelig-kreft-na-er-hapet-mer-kreftforskning/ 2024-12-11T11:16:37+00:00 https://www.lmi.no/2024/12/11/ny-og-viktig-behandling-for-kronisk-lymfatisk-leukemi/ 2024-12-11T11:17:31+00:00 https://www.lmi.no/2024/12/11/norsk-hematolog-tror-ny-kll-behandling-kan-bli-forstevalg-for-2030/ 2024-12-11T11:18:29+00:00 https://www.lmi.no/2024/12/11/arcticzymes-utvider-portefoljen/ 2024-12-11T11:19:37+00:00 https://www.lmi.no/2024/12/11/eli-lilly-lanserer-tilbakekjopsprogram-av-aksjer-for-15-milliarder-dollar/ 2024-12-11T11:20:30+00:00 https://www.lmi.no/2024/12/12/klimaendringene-slipper-los-zombievirus-doden-ligger-skjult-i-isen/ 2024-12-12T09:40:00+00:00 https://www.lmi.no/2024/12/12/anette-weyergang-karet-til-arets-kreftforsker-pa-ous/ 2024-12-12T09:41:03+00:00 https://www.lmi.no/2024/12/12/circio-vil-sette-ny-standard-for-genterapi/ 2024-12-12T09:42:13+00:00 https://www.lmi.no/2024/12/12/norske-funn-om-dosering-av-legemidler-sjelden-at-man-finner-sa-klare-signaler/ 2024-12-12T09:43:07+00:00 https://www.lmi.no/2024/12/12/lmis-generalforsamling-17-mars/ 2024-12-12T10:15:32+00:00 https://www.lmi.no/wp-content/uploads/2024/12/GF.jpg https://www.lmi.no/2024/12/12/helse-og-omsorgskomiteen-og-naeringskomiteen-har-levert-sin-innstilling-for-2025-budsjettet/ 2024-12-12T10:21:13+00:00 https://www.lmi.no/wp-content/uploads/2023/02/48973585938_88eb09a699_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/48973585938_88eb09a699_o-edited-scaled.jpg https://www.lmi.no/2024/12/13/brukte-167-millarder-dollar-pa-forskning-og-utvikling-i-2022/ 2024-12-13T11:29:32+00:00 https://www.lmi.no/wp-content/uploads/2024/12/IFPMArapport-forside.png https://www.lmi.no/wp-content/uploads/2024/12/IFPMArapport-forside.png https://www.lmi.no/2024/12/13/industriens-pipeline-moter-udekkede-medisinske-behov/ 2024-12-13T11:32:21+00:00 https://www.lmi.no/wp-content/uploads/2024/12/EFPIA-pipeline-report_forside-2.png https://www.lmi.no/2024/12/13/ny-rapport-slik-kan-norge-unnga-at-helsetjenesten-kollapser/ 2024-12-13T11:34:23+00:00 https://www.lmi.no/2024/12/13/dnb-anbefaler-kjop-av-zealand-pharma-aksjer/ 2024-12-13T11:35:22+00:00 https://www.lmi.no/2024/12/13/siemens-healthineers-sluttforer-kjopet-av-novartis-virksomhet/ 2024-12-13T11:36:26+00:00 https://www.lmi.no/2024/12/13/mener-apotektilvirkere-kan-spille-en-storre-beredskapsrolle/ 2024-12-13T11:37:31+00:00 https://www.lmi.no/2024/12/13/daiichi-sankyo-investerer-168-milliarder-kroner-i-kinesisk-fabrikk/ 2024-12-13T11:38:35+00:00 https://www.lmi.no/2024/12/13/den-svenske-regjeringen-satser-over-en-halv-milliard-kroner-pa-livsvitenskap/ 2024-12-13T11:39:35+00:00 https://www.lmi.no/2024/12/13/na-er-oncoinvent-pa-bors/ 2024-12-13T11:40:31+00:00 https://www.lmi.no/2024/12/15/dmp-har-ikke-retningslinjer-for-habilitetsvurdering/ 2024-12-15T19:30:41+00:00 https://www.lmi.no/2024/12/15/dystopisk-alarm-trussel-uten-sidestykke/ 2024-12-15T19:31:37+00:00 https://www.lmi.no/2024/12/15/chmp-anbefaler-17-legemidler-i-arets-siste-mote/ 2024-12-15T19:32:27+00:00 https://www.lmi.no/2024/12/15/benmargskreft-behandling-med-positive-resultater/ 2024-12-15T19:33:27+00:00 https://www.lmi.no/2024/12/16/dette-skjer-i-uke-51-budsjettbehandling-i-stortinget-og-i-helseforetakene/ 2024-12-16T09:05:17+00:00 https://www.lmi.no/2024/12/16/alvorlige-tilfeller-av-rsv-i-studie-pa-barn-far-fda-til-a-stanse-moderna-studie/ 2024-12-16T09:06:17+00:00 https://www.lmi.no/2024/12/16/bakterier-og-virus-pa-plast-overlever-renseanleggene-potensielt-farlig/ 2024-12-16T09:07:29+00:00 https://www.lmi.no/2024/12/16/mckinsey-skal-betale-650-millioner-dollar/ 2024-12-16T09:08:45+00:00 https://www.lmi.no/2024/12/16/novo-nordisk-bygger-nytt-pa-dansk-jord-investerer-milliarder-i-fabrikk-i-odense/ 2024-12-16T09:09:32+00:00 https://www.lmi.no/2024/12/13/medwatch-na-er-oncoinvent-pa-bors/ 2024-12-16T10:08:04+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-13-125745.png https://www.lmi.no/wp-content/uploads/2024/12/Skjermbilde-2024-12-13-125745.png https://www.lmi.no/2024/12/15/fikk-dodsdom-reddet-av-ny-medisin/ 2024-12-16T10:29:30+00:00 https://www.lmi.no/2024/12/17/fhi-mistanke-om-sjelden-bivirkning-av-slankemedisin/ 2024-12-17T09:07:20+00:00 https://www.lmi.no/2024/12/17/dansk-biotek-onsker-seg-et-europeisk-superfond/ 2024-12-17T09:08:14+00:00 https://www.lmi.no/2024/12/17/ge-healthcare-far-forskningsradet-stotte-til-baerekraftsprosjekt/ 2024-12-17T09:09:09+00:00 https://www.lmi.no/2024/12/17/forskning-viktige-medisiner-kan-vaere-kreftfremkallende/ 2024-12-17T09:10:08+00:00 https://www.lmi.no/2024/12/17/medisin-forlenger-tiden-for-brystkreft-kommer-tilbake-kan-endre-behandlingspraksis/ 2024-12-17T09:11:20+00:00 https://www.lmi.no/2024/12/17/exact-therapeutics-far-go-fra-fda-for-fase-2-studie/ 2024-12-17T09:12:40+00:00 https://www.lmi.no/2024/12/17/svensk-biotekselskap-med-norske-eiere-ligger-an-til-a-bli-kjopt/ 2024-12-17T09:13:56+00:00 https://www.lmi.no/2024/12/17/lytix-henter-over-100-millioner-kroner/ 2024-12-17T09:14:47+00:00 https://www.lmi.no/2024/12/16/frokostseminar-om-helsedata-nordisk-og-europeisk-samarbeid/ 2024-12-17T12:53:55+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Helsedata-AI-generert-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/12/Helsedata-AI-generert-Adobe-Stock-scaled.jpeg https://www.lmi.no/2024/12/17/gi-innspill-til-lmis-neste-strategi/ 2024-12-18T09:40:58+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Lets-go-2025.png https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/2024/12/18/dmp-setter-foten-ned-mens-sykehusinnkjop-lar-legene-vurdere-egen-habilitet/ 2024-12-18T09:44:17+00:00 https://www.lmi.no/2024/12/18/habilitetssak-kan-fa-konsekvenser-for-legemiddelanbud-og-kreftbehandling/ 2024-12-18T09:45:52+00:00 https://www.lmi.no/2024/12/18/zelluna-tar-kontroll-over-ultimovacs-i-strategisk-sammenslaing-toppsjef-gar-pa-dagen/ 2024-12-18T09:48:35+00:00 https://www.lmi.no/2024/12/18/pfizer-aksjonaerer-puster-lettet-ut-etter-2025-prognoser/ 2024-12-18T09:49:49+00:00 https://www.lmi.no/2024/12/18/legemiddel-fortsetter-a-beskytte-pasienter-mot-tilbakefall-av-brystkreft/ 2024-12-18T09:51:28+00:00 https://www.lmi.no/2024/12/18/resistent-hudsopp-sprer-seg-ogsa-i-norge/ 2024-12-18T09:53:40+00:00 https://www.lmi.no/2024/12/18/fda-utsetter-godkjenning-av-lungekreftbehandling-fra-johnson-johnson-etter-produksjonsanlegg-inspeksjon/ 2024-12-18T09:54:52+00:00 https://www.lmi.no/2024/12/18/nytt-mote-med-vestre-om-ventetid-pa-legemidler/ 2024-12-18T14:10:44+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Vestre-Venetid.png https://www.lmi.no/wp-content/uploads/2024/12/Vestre-Venetid.png https://www.lmi.no/2024/12/19/horingssvar-legemidler-som-kan-omsettes-utenom-apotek/ 2024-12-19T09:28:37+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/12/19/selger-eiendommer-til-oslo-science-hub-arets-julegave-til-kreftsaken/ 2024-12-19T09:47:33+00:00 https://www.lmi.no/2024/12/19/msd-inngar-milliardavtale-med-kinesisk-bioteknologiselskap-om-legemiddelkandidat-mot-fedme/ 2024-12-19T09:48:23+00:00 https://www.lmi.no/2024/12/19/bare-hver-fjerde-med-migrene-far-medisin-pa-resept-for-lisa-tok-det-20-ar/ 2024-12-19T09:49:48+00:00 https://www.lmi.no/2024/12/19/eli-lillys-alzheimer-behandling-far-tommel-opp-fra-kina/ 2024-12-19T09:50:47+00:00 https://www.lmi.no/2024/12/19/induct-far-astrazeneca-som-partner-i-storsatsing-pa-britiske-sykehus/ 2024-12-19T09:51:46+00:00 https://www.lmi.no/2024/12/19/historisk-norsk-vaksinestudie-langt-flere-uvaksinerte-dode/ 2024-12-19T09:55:01+00:00 https://www.lmi.no/2024/12/19/fagforbund-mener-novo-nordisk-trekker-opp-ingeniorlonningene-i-svensk-region/ 2024-12-19T09:56:21+00:00 https://www.lmi.no/2024/12/19/oslo-science-hubs-eiendomskjop-er-endelig-i-boks/ 2024-12-19T09:56:48+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Oslo-Science-Hub-5_Foto-Nordic-Office-of-Architecture.jpg https://www.lmi.no/wp-content/uploads/2024/12/Oslo-Science-Hub-1_Foto-Nordic-Office-of-Architecture-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/Oslo-Science-Hub-4_Foto-Nordic-Office-of-Architecture.jpg https://www.lmi.no/wp-content/uploads/2024/12/Thomas-London_Foto-Oslo-Science-Hub.jpeg https://www.lmi.no/2024/12/19/julebrev-2024-aret-som-har-gatt/ 2024-12-19T12:12:58+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Julebrev-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/12/Julebrev-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/Leif-Rune-Skymoen_portrett-nytt-scaled.jpg https://www.lmi.no/2024/12/20/svenske-bioarctic-og-bms-inngar-milliardavtale/ 2024-12-20T08:59:56+00:00 https://www.lmi.no/2024/12/20/who-legemidler-mot-overvekt-kan-bidra-til-a-stoppe-fedmepandemien/ 2024-12-20T09:00:48+00:00 https://www.lmi.no/2024/12/20/nye-styremedlemmer-i-exact-therapeutics-etter-ge-healthcare-investering/ 2024-12-20T09:39:00+00:00 https://www.lmi.no/2024/12/20/digitalis-tar-juleferie-3/ 2024-12-20T12:06:00+00:00 https://www.lmi.no/wp-content/uploads/2024/12/God_jul_kopi_med_tekst-1734611430.jpg https://www.lmi.no/wp-content/uploads/2024/12/God_jul_kopi_med_tekst-1734611430.jpg https://www.lmi.no/2025/01/02/vistin-pharma-avverget-tvangsmulkt-pa-en-halv-million-kroner/ 2025-01-02T08:45:10+00:00 https://www.lmi.no/2025/01/02/bristol-myers-squibb-far-godkjenning-for-ny-injeksjonsmetode-for-kreftlegemiddel/ 2025-01-02T08:47:52+00:00 https://www.lmi.no/2025/01/02/ny-analysemetode-fanger-opp-flere-med-diabetes-type-1-i-et-tidlig-stadium/ 2025-01-02T08:49:24+00:00 https://www.lmi.no/2025/01/02/usa-godkjenner-subkutan-versjon-av-immunterapien-opdivo/ 2025-01-02T09:09:37+00:00 https://www.lmi.no/2025/01/02/4-store-gjennombrudd-innen-helse-i-2024/ 2025-01-02T09:14:45+00:00 https://www.lmi.no/2025/01/02/kraftig-okning-i-norge-vaksinen-du-fikk-som-barn-gjelder-ikke-lenger/ 2025-01-02T09:15:50+00:00 https://www.lmi.no/2025/01/02/rod-loper-til-legemiddelproduksjon/ 2025-01-02T09:32:07+00:00 https://www.lmi.no/2025/01/02/demensforsker-aret-2024-har-blitt-et-vendepunkt-for-alzheimers/ 2025-01-02T09:36:56+00:00 https://www.lmi.no/2025/01/03/en-risiko-for-livet-pa-jorden-eksperter-advarer-mot-forskning-pa-spesielle-bakterier/ 2025-01-03T09:10:44+00:00 https://www.lmi.no/2025/01/03/arctic-bioscience-gjer-det-stort-i-kina/ 2025-01-03T09:22:32+00:00 https://www.lmi.no/2025/01/03/legemiddelselskaper-vil-oke-prisene-pa-mer-enn-250-medisiner-i-usa-i-2025/ 2025-01-03T09:24:30+00:00 https://www.lmi.no/2025/01/03/johnson-johnson-har-inngatt-lisensavtale-med-japansk-legemiddelselskap/ 2025-01-03T09:43:27+00:00 https://www.lmi.no/2025/01/03/novo-nordisk-er-ikke-lenger-europas-mest-verdifulle-selskap/ 2025-01-03T09:50:25+00:00 https://www.lmi.no/2025/01/03/slik-velges-legene-ut-som-eksperter-til-metodevurderinger/ 2025-01-03T09:53:00+00:00 https://www.lmi.no/2025/01/03/pfizer-avslutter-hemofili-samarbeid-med-amerikansk-biotekselskap/ 2025-01-03T09:55:20+00:00 https://www.lmi.no/2025/01/03/eli-lilly-vinner-importsak-usa-skal-stanse-ulovlige-kopier-ved-grensen/ 2025-01-03T09:57:55+00:00 https://www.lmi.no/2025/01/03/gjentatte-koronavaksiner-gir-god-beskyttelse-for-personer-med-nedsatt-immunforsvar/ 2025-01-03T10:00:33+00:00 https://www.lmi.no/2025/01/06/alle-trenger-at-direktoratet-for-medisinske-produkter-lykkes/ 2025-01-06T13:03:59+00:00 https://www.lmi.no/2025/01/06/eu-kommisjonen-godkjenner-ny-forstelinjebehandling-for-avansert-lungekreft/ 2025-01-06T13:07:07+00:00 https://www.lmi.no/2025/01/06/fire-onsker-til-ny-dmp-direktor/ 2025-01-06T13:08:47+00:00 https://www.lmi.no/2025/01/06/dette-skjer-i-helsepolitikken-i-uke-2-rushoring-interpellasjoner-og-horingsfrister/ 2025-01-06T13:10:17+00:00 https://www.lmi.no/2025/01/06/gsk-far-kina-godkjenning-for-behandling-av-alvorlig-bihulebetennelse/ 2025-01-06T13:11:37+00:00 https://www.lmi.no/2025/01/07/statusrapport-om-oppgjorsordning-for-blareseptlegemidler-med-konfidensielle-priser/ 2025-01-07T12:49:28+00:00 https://www.lmi.no/wp-content/uploads/2018/11/scanning-apotek2.jpg https://www.lmi.no/wp-content/uploads/2018/11/scanning-apotek2.jpg https://www.lmi.no/2025/01/08/rapport-roche-vil-omsette-for-mest-i-2025/ 2025-01-08T10:19:18+00:00 https://www.lmi.no/2025/01/08/fedmekandidater-pa-listen-over-de-25-viktigste-studiene-fra-amerikanske-legemiddelselskaper/ 2025-01-08T10:20:17+00:00 https://www.lmi.no/2025/01/08/ultimovacs-fusjonen-tungvektere-fra-biotekbransjen-inntar-styret-i-nye-zelluna/ 2025-01-08T10:21:33+00:00 https://www.lmi.no/2025/01/08/podcast-vil-eli-lilly-eller-novo-nordisk-vinne-krigen-om-slankemedisin/ 2025-01-08T10:22:23+00:00 https://www.lmi.no/2025/01/08/toppidrettsutover-inngar-samarbeidsavtale-med-legemiddelselskap/ 2025-01-08T10:23:20+00:00 https://www.lmi.no/2025/01/08/novartis-vil-na-flere-sma-pasienter-med-zolgensma-via-injeksjon-i-ryggmargen/ 2025-01-08T10:24:35+00:00 https://www.lmi.no/2025/01/08/forste-pasient-innrullert-i-bergenbio-studie/ 2025-01-08T10:25:30+00:00 https://www.lmi.no/2025/01/08/kinesisk-vaksineselskap-selger-anlegg-til-msd-for-500-millioner-dollar/ 2025-01-08T10:26:24+00:00 https://www.lmi.no/2025/01/08/eivind-jorgensen-er-ny-partner-i-oslo-economics/ 2025-01-08T10:27:23+00:00 https://www.lmi.no/2025/01/08/fda-presiserer-reglene-for-hurtiggodkjenning/ 2025-01-08T10:33:41+00:00 https://www.lmi.no/2025/01/08/lytix-dropper-planlagt-emisjon-til-eksisterende-aksjonaerer/ 2025-01-08T10:34:45+00:00 https://www.lmi.no/2025/01/08/prioriterte-ikke-hpv-vaksine-til-unge-menn-og-risikogrupper-skuffet/ 2025-01-08T10:35:37+00:00 https://www.lmi.no/2025/01/08/rsv-vaksiner-fra-gsk-og-pfizer-skal-merkes-med-advarsler-om-okt-risiko-for-sjelden-sykdom/ 2025-01-08T10:36:32+00:00 https://www.lmi.no/2025/01/08/ny-landssjef-for-novo-nordisk-i-danmark/ 2025-01-08T10:37:28+00:00 https://www.lmi.no/2025/01/08/lmi-inviterer-til-digitalt-medlemsmote/ 2025-01-08T14:34:46+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Medlemsmotet-18110-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/10/Medlemsmotet-18110-kopi.jpg https://www.lmi.no/2025/01/09/omprogrammerte-stamceller-gir-nytt-hap-for-diabetespasienter/ 2025-01-09T11:17:20+00:00 https://www.lmi.no/2025/01/09/bruk-av-adhd-medisin-til-himmels-lege-vegrer-seg-for-a-skrive-ut-resepter/ 2025-01-09T11:18:35+00:00 https://www.lmi.no/2025/01/09/slankesproyter-er-milliardbutikk-i-norge-christer-har-fatt-et-helt-nytt-liv/ 2025-01-09T11:21:36+00:00 https://www.lmi.no/2025/01/09/hyller-danmarks-strategiske-grep-for-helsenaeringen-mener-norge-bor-ha-mindre-beroringsangst/ 2025-01-09T11:27:43+00:00 https://www.lmi.no/2025/01/09/nye-oyceller-testes-for-transplantasjon-uten-immundempende-medisiner/ 2025-01-09T11:28:58+00:00 https://www.lmi.no/2025/01/09/nykode-med-studieoppdatering-aksjen-stiger-kraftig/ 2025-01-09T11:30:05+00:00 https://www.lmi.no/2025/01/09/wallenberg-mener-eu-taper-mot-usa-har-ingen-sykdomsinnsikt/ 2025-01-09T11:31:41+00:00 https://www.lmi.no/2025/01/09/helge-lund-om-novo-nordisks-suksessoppskrift-trekker-til-seg-veldig-flinke-folk/ 2025-01-09T11:34:28+00:00 https://www.lmi.no/2025/01/09/novo-nordisk-betalte-britiske-apotek-for-a-oke-salget-av-fedmemedisin/ 2025-01-09T11:59:17+00:00 https://www.lmi.no/2025/01/08/thor-medical-tildeles-lan-pa-90-millioner-kroner/ 2025-01-09T12:10:05+00:00 https://www.lmi.no/wp-content/uploads/2023/10/stortinget-Leif-Rune-Skymoen-Monica-Larsen-2964-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Thor-Medical.jpg https://www.lmi.no/wp-content/uploads/2023/10/stortinget-Leif-Rune-Skymoen-Monica-Larsen-2964-scaled.jpg https://www.lmi.no/2025/01/10/presentasjoner-fra-helsedatamotet/ 2025-01-10T08:00:20+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Presentasjon-skjermbilde-helsedatamote.png https://www.lmi.no/wp-content/uploads/2025/01/MarianneMarkusIna-helsedatamotet.png https://www.lmi.no/2025/01/09/european-health-data-space-vil-knytte-de-nordiske-landene-tettere-sammen/ 2025-01-10T08:01:00+00:00 https://www.lmi.no/wp-content/uploads/2024/12/Helsedata-AI-generert-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/12/Helsedata-AI-generert-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/01/Marianne-van-Os.jpg https://www.lmi.no/wp-content/uploads/2025/01/markus_kalliola_vaaka_crop.jpg https://www.lmi.no/2025/01/10/hvem-jobber-med-kvinnehelse/ 2025-01-10T09:43:23+00:00 https://www.lmi.no/wp-content/uploads/2025/01/DALL%C2%B7E-2025-01-08-15.58.11-An-illustration-focused-on-womens-health-showing-diverse-women-of-various-ages-and-ethnicities-in-a-medical-and-healthcare-setting.-The-scene-includ-2.webp https://www.lmi.no/2025/01/10/trumps-gronland-planer-kan-gjore-ozempic-dyrere/ 2025-01-10T10:13:38+00:00 https://www.lmi.no/2025/01/10/debatt-mange-enere-fa-enhjorninger/ 2025-01-10T10:15:25+00:00 https://www.lmi.no/2025/01/10/johnson-johnson-slar-astrazeneca-i-egen-head-to-head-studie/ 2025-01-10T10:16:22+00:00 https://www.lmi.no/2025/01/10/nytt-forsok-pa-a-fa-ibux-ut-av-butikken/ 2025-01-10T10:17:18+00:00 https://www.lmi.no/2025/01/10/novo-og-valo-health-gar-sammen-utvikler-medisiner-mot-kardiometabolske-sykdommer/ 2025-01-10T10:18:13+00:00 https://www.lmi.no/2025/01/10/norge-ruster-opp-mot-fugleinfluensa/ 2025-01-10T10:19:35+00:00 https://www.lmi.no/2025/01/10/jp-morgan-novo-nordisk-pa-vei-med-solid-prognose-for-2025/ 2025-01-10T10:20:27+00:00 https://www.lmi.no/2025/01/10/digitalt-medlemsmote-om-legemiddelberedskap-31-januar/ 2025-01-10T10:38:22+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Beredskapslagre-av-Dall-E.png https://www.lmi.no/wp-content/uploads/2024/01/Beredskapslagre-av-Dall-E.png https://www.lmi.no/2025/01/10/lmi-om-totalberedskapsmeldingen-det-haster-a-fa-norge-inn-i-hera/ 2025-01-13T08:24:06+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/2025/01/13/totalberedskapsmeldingen-lmi-savner-tiltak-for-legemiddelberedskap/ 2025-01-13T10:29:36+00:00 https://www.lmi.no/2025/01/13/ny-bergenbio-sjef-om-kritiske-data-i-2025-blir-en-viktig-avlesing-for-oss/ 2025-01-13T10:32:12+00:00 https://www.lmi.no/2025/01/13/artbio-henter-medisinsk-direktor-fra-johnson-johnson/ 2025-01-13T10:33:32+00:00 https://www.lmi.no/2025/01/13/her-er-salgstallene-for-det-nye-vektreduserende-legemiddelet-mounjaro/ 2025-01-13T10:34:47+00:00 https://www.lmi.no/2025/01/13/kreftpasient-far-ikke-kostbar-behandling-pengene-er-viktigere-enn-pasientene/ 2025-01-13T10:36:01+00:00 https://www.lmi.no/2025/01/13/na-skal-legemidler-og-utstyr-metodevurderes-pa-eu-niva-vi-haper-at-dette-blir-bedre-for-pasientene/ 2025-01-13T11:04:08+00:00 https://www.lmi.no/2025/01/13/helsebedriftene-i-nho-oker-andelen-gronne-investeringer/ 2025-01-13T11:05:56+00:00 https://www.lmi.no/2025/01/13/pille-kan-hjelpe-15-milliarder-mennesker-meget-lovende/ 2025-01-13T11:09:05+00:00 https://www.lmi.no/2025/01/13/nye-funn-kan-gi-bedre-behandling-mot-leukemi/ 2025-01-13T11:10:18+00:00 https://www.lmi.no/2025/01/13/danske-leo-pharma-inngar-milliardavtale-med-gilead/ 2025-01-13T11:11:53+00:00 https://www.lmi.no/2025/01/13/ane-gerda-zahl-eriksson-er-ny-leder-for-gyn-onkologene-pa-radiumhospitalet/ 2025-01-13T11:13:03+00:00 https://www.lmi.no/2025/01/13/induct-skal-lette-pa-sloret-om-samarbeid-med-legemiddelgigant/ 2025-01-13T11:14:24+00:00 https://www.lmi.no/2025/01/13/innspill-til-ny-hjernehelsestrategi/ 2025-01-13T12:55:27+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2023/10/AdobeStock_hjerne-scaled.jpeg https://www.lmi.no/2025/01/13/lmis-horingssvar-pa-omfattende-lovendringer/ 2025-01-13T14:47:30+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Ina-Dahlsveen_portrett_edited.jpg https://www.lmi.no/wp-content/uploads/2023/01/Ina-Kathrine-Dahlsveen-5755-scaled.jpg https://www.lmi.no/2025/01/18/johnson-johnson-gjor-biotek-bransjens-storste-oppkjop-pa-over-ett-ar/ 2025-01-18T10:12:10+00:00 https://www.lmi.no/2025/01/18/gsk-kjoper-biotek-selskap-for-over-13-milliarder-kroner/ 2025-01-18T10:13:13+00:00 https://www.lmi.no/2025/01/18/slankemiddelgigant-truer-med-utflagging/ 2025-01-18T10:14:46+00:00 https://www.lmi.no/2025/01/18/biogen-vil-kjope-kriserammet-partner-bak-tablett-mot-fodselsdepresjon/ 2025-01-18T10:15:53+00:00 https://www.lmi.no/2025/01/18/debatt-skal-man-tvinge-alle-som-har-fatt-offentlig-utdanning-til-a-jobbe-i-det-offentlige/ 2025-01-18T13:34:06+00:00 https://www.lmi.no/2025/01/18/wegovy-er-norges-storste-medisin-omsatte-for-15-milliarder-kroner-i-2024/ 2025-01-18T13:35:27+00:00 https://www.lmi.no/2025/01/18/eli-lilly-kjoper-kreftselskap-for-opptil-285-milliarder-kroner/ 2025-01-18T13:36:20+00:00 https://www.lmi.no/2025/01/18/askil-27-mistet-haret-som-tenaring-fikk-mange-kommentarer/ 2025-01-18T13:37:32+00:00 https://www.lmi.no/2025/01/18/debatt-norske-pasienter-lider-og-dor-helt-unodvendig/ 2025-01-18T13:38:59+00:00 https://www.lmi.no/2025/01/18/norske-apotek-solgte-ozempic-og-wegovy-for-375-milliarder-kroner-i-2024/ 2025-01-18T13:39:59+00:00 https://www.lmi.no/2025/01/18/banebrytende-studie-overrasker-kan-redde-liv/ 2025-01-18T13:41:00+00:00 https://www.lmi.no/2025/01/18/anstrengt-sykehusokonomi-mer-gjeld-storre-forventninger-og-mangel-pa-arbeidskraft/ 2025-01-18T13:41:52+00:00 https://www.lmi.no/2025/01/18/vestre-besokte-sykehusinnkjop-imponert-over-det-dere-gjor/ 2025-01-18T13:43:04+00:00 https://www.lmi.no/2025/01/18/debatt-hvorfor-sa-lave-vaksineambisjoner/ 2025-01-18T13:44:28+00:00 https://www.lmi.no/2025/01/18/debatt-fempunktsliste-til-vestre-kortere-helsekoer-med-bedre-legemiddelbehandling/ 2025-01-18T13:46:07+00:00 https://www.lmi.no/2025/01/18/toppsjefen-for-apotek-1-gruppen-fratrer/ 2025-01-18T13:47:06+00:00 https://www.lmi.no/2025/01/18/slankemedisin-og-lego-kan-det-bli-danmarks-svar-pa-truslene/ 2025-01-18T13:48:14+00:00 https://www.lmi.no/2025/01/18/reagerer-pa-sykehuspraksis-barn-blir-traumatisert/ 2025-01-18T13:49:21+00:00 https://www.lmi.no/2025/01/18/robert-f-kennedy-jr-tjente-millioner-pa-vaksinelogner/ 2025-01-18T13:50:48+00:00 https://www.lmi.no/2025/01/18/vestre-lover-at-helsekoene-skal-markant-ned-vil-se-pa-kapasitet-hos-private/ 2025-01-18T13:51:44+00:00 https://www.lmi.no/2025/01/18/sharelab-selskapene-hentet-over-en-milliard-kroner-i-2024/ 2025-01-18T13:52:33+00:00 https://www.lmi.no/2025/01/18/se-opp-for-disse-11-legemidlene-i-2025/ 2025-01-18T13:54:58+00:00 https://www.lmi.no/2025/01/18/viruset-ligger-i-dvale-hos-alle-nordmenn-forferdelig-smerte/ 2025-01-18T13:56:18+00:00 https://www.lmi.no/2025/01/18/denne-presisjonsmedisinen-har-endret-behandlingen-av-brystkreft/ 2025-01-18T13:57:28+00:00 https://www.lmi.no/2025/01/18/sanofi-etterlyser-finansieringslosning-for-pasienter-med-sjeldne-sykdommer/ 2025-01-18T13:58:29+00:00 https://www.lmi.no/2025/01/18/mario-klesse-blir-nordensjef-i-johnson-johnson/ 2025-01-18T13:59:46+00:00 https://www.lmi.no/2025/01/18/pfizers-blaerekreftbehandling-oppnar-hovedmalet-i-senfase-studie/ 2025-01-18T14:00:38+00:00 https://www.lmi.no/2025/01/18/novo-nordisk-ut-mot-amerikansk-prisregulering-vil-bremse-forskning-og-utvikling/ 2025-01-18T14:02:09+00:00 https://www.lmi.no/2025/01/18/legemiddelprodusenter-forbereder-seg-pa-nye-medicare-forhandlinger/ 2025-01-18T14:03:36+00:00 https://www.lmi.no/2025/01/18/bivirkningskomite-gransker-semaglutid/ 2025-01-18T14:04:50+00:00 https://www.lmi.no/2025/01/18/beslutningsforum-vurderer-nye-priser-pa-medisiner-mot-lungekreft-og-blodkreft/ 2025-01-18T14:05:50+00:00 https://www.lmi.no/2025/01/18/bioarctic-felt-for-uttalelser-til-journalist-etter-klage-fra-konkurrent/ 2025-01-18T14:07:00+00:00 https://www.lmi.no/2025/01/18/lang-saksliste-pa-arets-forste-beslutningsforum/ 2025-01-18T14:07:57+00:00 https://www.lmi.no/2025/01/18/tidligere-fda-topp-mener-kennedy-jr-kan-undergrave-tilliten-til-vaksiner/ 2025-01-18T14:08:58+00:00 https://www.lmi.no/2025/01/20/stor-studie-risikoen-for-hjerneslag-kan-avleses-i-oyet-ditt/ 2025-01-20T09:46:36+00:00 https://www.lmi.no/2025/01/20/nobelprisvinner-designet-helt-ny-motgift-mot-slangebitt/ 2025-01-20T09:47:46+00:00 https://www.lmi.no/2025/01/20/dette-skjer-i-uke-4-vaksineanbefaling-og-ekstraordinaert-styremote/ 2025-01-20T09:48:35+00:00 https://www.lmi.no/2025/01/20/astrazeneca-utnevner-nye-sjefer-i-kina/ 2025-01-20T09:51:35+00:00 https://www.lmi.no/2025/01/20/lmis-horingssvar-til-endringer-i-folkehelseloven/ 2025-01-20T13:22:09+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/2025/01/20/naeringsbyraden-pa-besok-hos-ge-healthcare/ 2025-01-20T14:21:02+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Naeringsbyraden-pa-GE-besok-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Naeringsbyraden-pa-GE-besok-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Naeringsbyraden-pa-GE-besok-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Naeringsbyraden-pa-GE-besok_1-scaled.jpg https://www.lmi.no/2025/01/13/seminar-for-pasientforeninger/ 2025-01-21T07:08:24+00:00 https://www.lmi.no/wp-content/uploads/2025/01/pasientforeninger-og-legemiddelindustrien-Arr_bilde-550x413-1.jpg https://www.lmi.no/2025/01/21/ad-pd-konferansen-presenterer-norge-som-studieland/ 2025-01-21T11:53:42+00:00 https://www.lmi.no/wp-content/uploads/2025/01/AdobeStock_Wien-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/01/AdobeStock_Wien-scaled.jpeg https://www.lmi.no/2025/01/22/gsk-debatten-i-opplopet-til-anbudsresultatet-har-vaert-unyansert/ 2025-01-22T13:32:11+00:00 https://www.lmi.no/2025/01/22/debatt-nye-metoder-fungerer-ikke-etter-den-politiske-hensikten-slik-kan-det-forbedres/ 2025-01-22T13:33:43+00:00 https://www.lmi.no/2025/01/22/ny-behandling-mot-forkalkning-pa-oyet-%e2%81%a0-dette-er-virkelig-gledelig/ 2025-01-22T13:34:50+00:00 https://www.lmi.no/2025/01/22/noen-fa-medisiner-utgjor-halvparten-av-kostnadene/ 2025-01-22T13:42:05+00:00 https://www.lmi.no/2025/01/22/nye-behandlinger-innfores-for-lungekreft-og-lymfom/ 2025-01-22T13:46:23+00:00 https://www.lmi.no/2025/01/22/cervarix-er-hpv-vaksinen-som-blir-valgt-til-barnevaksinasjonsprogrammet/ 2025-01-22T13:47:29+00:00 https://www.lmi.no/2025/01/22/columvi-godkjent-som-behandling-av-agressiv-blodkreft/ 2025-01-22T13:48:25+00:00 https://www.lmi.no/2025/01/22/beslutningsforum-sier-ja-til-syv-og-nei-til-fem-legemidler/ 2025-01-22T13:55:17+00:00 https://www.lmi.no/2025/01/22/fda-godkjenner-ny-adc-medisin-mot-brystkreft/ 2025-01-22T13:56:31+00:00 https://www.lmi.no/2025/01/22/hoyre-politiker-vil-ta-hpv-beslutning-til-stortinget-skuffende/ 2025-01-22T13:57:18+00:00 https://www.lmi.no/2025/01/22/hpv-anbudet-stiller-oss-uforstaende-til-myndighetenes-vurdering/ 2025-01-22T13:58:26+00:00 https://www.lmi.no/2025/01/22/trump-trekker-usa-fra-verdens-helseorganisasjon/ 2025-01-22T13:59:27+00:00 https://www.lmi.no/2025/01/22/who-haper-trump-revurderer-a-trekke-usa-fra-organisasjonen/ 2025-01-22T14:00:34+00:00 https://www.lmi.no/2025/01/22/fagdirektor-om-lmi-betalt-artikkel-dette-gjor-prioritering-vanskeligere/ 2025-01-22T14:01:40+00:00 https://www.lmi.no/2025/01/22/debatt-vraker-den-beste-hpv-vaksinen/ 2025-01-22T14:02:58+00:00 https://www.lmi.no/2025/01/22/ous-lege-om-hpv-avgjorelse-vi-er-ekstremt-skuffet/ 2025-01-22T14:04:04+00:00 https://www.lmi.no/2025/01/22/novartis-toppsjefen-ser-muligheter-etter-trump-seier/ 2025-01-22T14:41:46+00:00 https://www.lmi.no/2025/01/22/slik-skal-dmp-kartlegge-alle-norske-apotek/ 2025-01-22T14:42:41+00:00 https://www.lmi.no/2025/01/22/gsk-far-utvidet-godkjenning-i-eu-for-kreftlegemiddel-gar-inn-i-beslutningsforums-hurtigspor/ 2025-01-22T14:43:37+00:00 https://www.lmi.no/2025/01/22/ma-ta-politiske-grep-for-a-fa-ned-ventetiden-pa-legemidler/ 2025-01-23T08:14:18+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-med-Vestre_statsbudsjettet-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/Skymoen-med-Vestre_statsbudsjettet-2025-scaled.jpg https://www.lmi.no/2025/01/24/lang-ventetid-pa-nye-legemidler-nytt-dialogmote-ga-ingen-svar/ 2025-01-24T09:18:24+00:00 https://www.lmi.no/2025/01/24/derfor-stoppet-farmastat-a-rapportere-apne-salgstall-pa-legemidler/ 2025-01-24T09:28:56+00:00 https://www.lmi.no/2025/01/24/johnson-johnson-slar-resultatforventningene-for-fjerde-kvartal/ 2025-01-24T09:30:00+00:00 https://www.lmi.no/2025/01/24/debatt-supersatsing-pa-metodevurdering/ 2025-01-24T09:31:08+00:00 https://www.lmi.no/2025/01/24/etter-15-ar-er-nye-retningslinjer-om-overvekt-og-fedme-pa-vei/ 2025-01-24T09:32:11+00:00 https://www.lmi.no/2025/01/24/hvor-mange-viruspartikler-skal-til-for-a-gjore-oss-syke/ 2025-01-24T09:33:39+00:00 https://www.lmi.no/2025/01/24/mot-dmps-nye-leder-pa-lmis-medlemsmote/ 2025-01-24T20:26:45+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Trygve-Ottersen-bredde-550x412-1.jpg https://www.lmi.no/wp-content/uploads/2025/01/trygve-ottersen-screenshot.png https://www.lmi.no/2025/01/24/anders-goransson-er-ny-administrerende-direktor-i-link-medical/ 2025-01-24T20:40:12+00:00 https://www.lmi.no/wp-content/uploads/2025/01/anders-web-link-med-1200x600-1.jpg https://www.lmi.no/wp-content/uploads/2025/01/anders-web-link-med-1200x600-1.jpg https://www.lmi.no/2025/01/27/jemperli-kombinasjon-utvides-til-flere-pasienter-med-livmorkreft/ 2025-01-27T11:26:52+00:00 https://www.lmi.no/2025/01/27/novo-nordiskneste-generasjons-fedmebehandling-viser-lovende-resultater-gir-22-prosent-vekttap-i-tidlig-studie/ 2025-01-27T11:28:18+00:00 https://www.lmi.no/2025/01/27/enorm-studie-slankemedisin-knyttet-til-hoyere-risiko-for-smertefull-sykdom/ 2025-01-27T11:29:23+00:00 https://www.lmi.no/2025/01/27/dette-skjer-i-uke-5-horinger-og-samarbeidsavtale-med-tyskland/ 2025-01-27T11:30:21+00:00 https://www.lmi.no/2025/01/27/genetic-analysis-inngar-samarbeid-med-ferring-pharmaceuticals/ 2025-01-27T11:31:15+00:00 https://www.lmi.no/2025/01/27/robert-f-kennedy-granskes-for-okonomisk-vinning-i-soksmal-mot-msd/ 2025-01-27T11:32:05+00:00 https://www.lmi.no/2025/01/28/nye-oppdagelser-i-kampen-mot-huntingtons/ 2025-01-28T10:39:58+00:00 https://www.lmi.no/2025/01/28/eisai-og-biogen-far-godkjent-manedlig-alzheimers-behandling-i-usa/ 2025-01-28T10:40:59+00:00 https://www.lmi.no/2025/01/28/norsk-ingeniorfirma-skal-muliggjore-belgisk-isotop-produksjon/ 2025-01-28T10:41:55+00:00 https://www.lmi.no/2025/01/28/ser-stralende-muligheter-i-oncoinvent/ 2025-01-28T10:43:43+00:00 https://www.lmi.no/2025/01/28/fortsatt-mulig-a-gi-innspill-til-lmis-neste-strategi/ 2025-01-28T12:10:22+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/2025/01/29/utkast-til-lmis-bransjeregler-2025/ 2025-01-29T09:03:45+00:00 https://www.lmi.no/wp-content/uploads/2016/08/loverregler_mindre_LMI-lilla-bl%C3%A5.jpg https://www.lmi.no/2025/01/29/bayer-koblet-norsk-firma-med-belgisk-produsent/ 2025-01-29T09:07:03+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Bilde-Cody-PanTera-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Bilde-Cody-PanTera-1-1-scaled.jpg https://www.lmi.no/2025/01/29/loypemelding-for-voksenvaksinasjonsprogrammet/ 2025-01-29T09:44:51+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Panel-DM-Arena-vaksiner-25-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Panel-DM-Arena-vaksiner-25-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/anne-margrethe-crop-2-scaled-e1748933566845.jpg https://www.lmi.no/2025/01/29/ozempic-godkjent-til-reduksjon-av-nyresykdom-og-hjerte-kar-dod-i-usa/ 2025-01-29T10:43:46+00:00 https://www.lmi.no/2025/01/29/positive-resultater-i-sen-fase-av-studie-pa-duchennes-muskeldystrofi/ 2025-01-29T10:44:52+00:00 https://www.lmi.no/2025/01/29/vestre-mener-nei-til-energidirektiver-kan-sette-helseavtale-med-eu-i-fare/ 2025-01-29T10:45:51+00:00 https://www.lmi.no/2025/01/29/inhabile-disse-legene-fikk-ikke-delta-i-metodevurderinger-i-2024/ 2025-01-29T10:50:07+00:00 https://www.lmi.no/2025/01/29/bare-en-dose-av-et-nytt-legemiddel-nedkjempet-svulster-hos-mus/ 2025-01-29T10:50:57+00:00 https://www.lmi.no/2025/01/29/store-ulikheter-i-bruk-av-slankemedisin-for-fedmeoperasjon/ 2025-01-29T10:51:52+00:00 https://www.lmi.no/2025/01/29/exact-therapeutics-kunngjor-resultater-fra-tidlig-forskning-pa-aggressiv-kreftform/ 2025-01-29T10:52:40+00:00 https://www.lmi.no/2025/01/29/innspill-til-styrekandidater-i-lmi-5/ 2025-01-29T12:13:39+00:00 https://www.lmi.no/wp-content/uploads/2025/01/DALL%C2%B7E-2025-01-09-15.11.45-An-elegant-illustration-designed-for-a-board-member-election-showing-a-diverse-group-of-professionals-with-a-focus-on-gender-balance-more-women-tha.jpg https://www.lmi.no/wp-content/uploads/2025/01/DALL%C2%B7E-2025-01-09-15.11.45-An-elegant-illustration-designed-for-a-board-member-election-showing-a-diverse-group-of-professionals-with-a-focus-on-gender-balance-more-women-tha.jpg https://www.lmi.no/2025/01/30/disse-fikk-utbetalt-mest-fra-industrien-i-2023/ 2025-01-30T08:59:29+00:00 https://www.lmi.no/2025/01/30/sa-mye-betalte-legemiddelfirmaene-ut-i-2023/ 2025-01-30T09:30:55+00:00 https://www.lmi.no/2025/01/30/ous-direktoren-vil-stramme-inn-regelverket-for-utbetalinger-fra-industrien/ 2025-01-30T09:32:54+00:00 https://www.lmi.no/2025/01/30/hun-har-siktet-inn-konkurranse-kompasset-slik-skal-europa-bli-en-okonomisk-stormakt/ 2025-01-30T09:34:05+00:00 https://www.lmi.no/2025/01/30/regjeringsstriden-kan-stikke-kjepper-i-hjulene-for-helseavtale-med-eu/ 2025-01-30T09:34:54+00:00 https://www.lmi.no/2025/01/30/biogens-kriserammede-partner-avviser-oppkjopstilbud-vil-se-pa-andre-alternativer/ 2025-01-30T09:35:43+00:00 https://www.lmi.no/2025/01/30/tapte-hpv-anbudskonkurranse-anker-ikke/ 2025-01-30T09:40:08+00:00 https://www.lmi.no/2025/01/30/millioner-av-nordmenn-vil-ned-i-vekt-frykter-klasseskille-pa-slankemedisin/ 2025-01-30T09:41:11+00:00 https://www.lmi.no/2025/01/30/inngar-nordisk-salgsavtale-om-legemiddel-mot-sjelden-sykdom/ 2025-01-30T09:41:58+00:00 https://www.lmi.no/2025/01/30/dorejd-kastrati-er-ny-medisinsk-direktor-hos-boehringer-ingelheim-danmark-og-norge/ 2025-01-30T09:43:00+00:00 https://www.lmi.no/2025/01/30/arrangerte-seminar-for-pasientforeninger/ 2025-01-30T13:16:40+00:00 https://www.lmi.no/wp-content/uploads/2025/01/IMG_5176-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/IMG_5176-scaled.jpg https://www.lmi.no/2023/11/07/presentasjoner-fra-regulatorisk-hostmote-2023/ 2025-01-30T16:12:08+00:00 https://www.lmi.no/wp-content/uploads/2023/10/8BC7BF4F-8C6C-454A-B9AB-ADCF3A0EAC79-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/4C0C7544-4637-45A4-87C8-FDE08D29BB23-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/886E135B-ACA8-4F0F-8063-BF93922965CC-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/38609045-ACBB-4FEB-B88E-B78E89004B1B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/CC57CE2D-BBBC-4B4F-9D59-007330BF3CCB-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/4C0C7544-4637-45A4-87C8-FDE08D29BB23-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/CB98860A-0902-4F12-B811-C1A37217040B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/4088D195-BB80-4C27-A842-D70A08E653D1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/FBEE2814-E9CC-4586-9237-36545D9C9C5D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/6D00D40B-0A72-496A-A2D6-119F72D379AE-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/88805F63-4647-4E0D-8644-52754CE2DF29-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/3A38BA39-861A-4FA9-A10F-25E1E379326C-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/8EFD5C0D-366D-4E3C-AD77-9DCDA9012224-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/82B61C7A-D926-4AAC-ABB5-AB3BBF5B115A-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/EF237240-50FA-4BB8-BF19-2CB7BB388C24-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/62B4A320-60EB-4331-B7FC-946F7F98C9E0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/5FDF6F17-3882-4D6B-BDB9-0884FEAC64A6-scaled.jpeg https://www.lmi.no/2025/01/31/disse-skal-smi-sammen-biotek-norge-med-nytt-akseleratorprogram/ 2025-01-31T10:35:30+00:00 https://www.lmi.no/2025/01/31/en-enkel-ukentlig-rutine-kan-kanskje-redusere-risikoen-for-hjerneslag/ 2025-01-31T10:57:50+00:00 https://www.lmi.no/2025/01/31/inngar-nordisk-salgsavtale-om-distribusjon-av-legemiddel/ 2025-01-31T11:02:25+00:00 https://www.lmi.no/2025/01/31/studie-helsekostnader-ved-nye-legemidler-overstiger-helsegevinsten/ 2025-01-31T11:05:56+00:00 https://www.lmi.no/2025/01/31/takeda-far-sin-forste-kvinnelige-toppsjef-i-selskapets-240-ar-lange-historie/ 2025-01-31T11:07:12+00:00 https://www.lmi.no/2025/01/31/lmi-mener-britisk-studie-bommer/ 2025-01-31T11:10:17+00:00 https://www.lmi.no/2025/01/31/denne-jobben-er-ikke-sa-ille-som-folk-vil-ha-det-til/ 2025-01-31T11:11:17+00:00 https://www.lmi.no/2025/01/31/medwatch-lmi-mener-britisk-studie-bommer/ 2025-01-31T11:16:58+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Skjermbilde-2025-01-31-121431.png https://www.lmi.no/wp-content/uploads/2025/01/Skjermbilde-2025-01-31-121431.png https://www.lmi.no/2025/01/31/de-fleste-av-oss-onsker-a-ga-ned-i-vekt/ 2025-01-31T12:21:23+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Fedmerapporten-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/01/Fedmerapporten-2025-scaled.jpg https://www.lmi.no/2025/01/31/okning-i-antall-kliniske-studier-i-2024/ 2025-01-31T12:59:53+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Ingvil-Saeterdal-og-Ina-Dahlsveen.png https://www.lmi.no/wp-content/uploads/2025/01/image.jpeg https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop-1.png https://www.lmi.no/2025/02/03/debatt-det-er-full-apenhet-om-verdioverforinger/ 2025-02-03T09:28:53+00:00 https://www.lmi.no/2025/02/03/over-400-pagrepet-i-aksjon-mot-falske-legemidler/ 2025-02-03T09:30:08+00:00 https://www.lmi.no/2025/02/03/fugleinfluensa-i-usa-gir-okte-eggpriser-og-pandemi-risiko-svaert-sannsynlig-med-smitte-mellom-mennesker-sier-norsk-forsker/ 2025-02-03T09:31:06+00:00 https://www.lmi.no/2025/02/03/svak-okning-i-kliniske-studier-av-legemidler/ 2025-02-03T09:32:07+00:00 https://www.lmi.no/2025/02/03/vi-har-fatt-et-samfunn-som-er-ekstremt-fedmefremkallende/ 2025-02-03T09:33:22+00:00 https://www.lmi.no/2025/02/03/atte-nye-legemidler-far-en-anbefaling-fra-chmp-i-januar/ 2025-02-03T09:34:09+00:00 https://www.lmi.no/2025/02/03/kreftforeningen-skal-finansiere-norsk-utprovende-kreftmedisin/ 2025-02-03T09:35:21+00:00 https://www.lmi.no/2025/02/03/industriutbetalinger-og-habilitet-helland-gjor-jobben-sykehuset-far-pengene/ 2025-02-03T09:36:14+00:00 https://www.lmi.no/2025/02/03/varsler-stort-kreftgjennombrudd/ 2025-02-03T09:37:03+00:00 https://www.lmi.no/2025/02/03/her-kan-du-soke-i-industriens-utbetalinger-til-helsepersonell-og-organisasjoner/ 2025-02-03T09:37:55+00:00 https://www.lmi.no/2025/02/03/debatt-losningen-pa-helseberedskap-er-utenfor-eus-helseunion/ 2025-02-03T09:39:04+00:00 https://www.lmi.no/2025/02/03/dette-skjer-i-uke-6-far-vi-ny-helseminister/ 2025-02-03T09:39:55+00:00 https://www.lmi.no/2025/02/03/astrazeneca-dropper-milliardinvestering-i-fabrikk/ 2025-02-03T09:40:45+00:00 https://www.lmi.no/2025/02/03/lmis-hausken-blant-de-forste-som-forsket-pa-legemiddelregisterets-data/ 2025-02-03T11:02:44+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Kari-og-Anne-Margrethe-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Kari-og-Anne-Margrethe-scaled.jpg https://www.lmi.no/2025/02/03/ny-sjef-i-nomvec/ 2025-02-03T12:00:55+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Sissel.jpg https://www.lmi.no/wp-content/uploads/2025/02/Sissel.jpg https://www.lmi.no/2025/02/04/helsedata-gir-oss-de-svarene-kliniske-studier-ikke-kan-gi/ 2025-02-04T10:32:58+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Pal-Hasvold_FHIseminar-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Pal-Hasvold_FHIseminar-scaled.jpg https://www.lmi.no/2025/02/04/gikk-nylig-av-som-sjef-for-link-medical-na-skal-hun-lede-nomvec/ 2025-02-04T10:47:51+00:00 https://www.lmi.no/2025/02/04/eu-kan-avfyre-nytt-vapen-mot-trump/ 2025-02-04T10:50:34+00:00 https://www.lmi.no/2025/02/04/debatt-ny-lov-om-helseforskning-kan-true-sikkerheten-til-pasientene/ 2025-02-04T10:52:24+00:00 https://www.lmi.no/2025/02/04/truet-vaksineprodusent-skal-fa-alle-ansatte-drept/ 2025-02-04T10:53:07+00:00 https://www.lmi.no/2025/02/04/hun-blir-ny-teknologidirektor-i-lytix-biopharma/ 2025-02-04T10:53:56+00:00 https://www.lmi.no/2025/02/04/historisk-mange-soksmal-mot-novo-nordisk/ 2025-02-04T10:54:49+00:00 https://www.lmi.no/2025/02/03/se-medlemsmotet-om-beredskap-her/ 2025-02-05T11:55:58+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Medlemsmote-3101.png https://www.lmi.no/wp-content/uploads/2025/02/Medlemsmote-3101.png https://www.lmi.no/2025/02/06/tilbake-i-industrien-for-a-jakte-falske-legemidler/ 2025-02-06T10:34:50+00:00 https://www.lmi.no/2025/02/06/pfizer-selger-bedre-enn-ventet-og-bekrefter-2025-prognose/ 2025-02-06T10:35:37+00:00 https://www.lmi.no/2025/02/06/relis-cervarix-gir-like-god-beskyttelse-mot-kreft-som-gardasil-9/ 2025-02-06T10:36:36+00:00 https://www.lmi.no/2025/02/06/demokrater-krever-at-robert-f-kennedy-jr-trekker-seg-fra-vaksinesaker/ 2025-02-06T10:37:34+00:00 https://www.lmi.no/2025/02/06/dmp-direktoren-etterspor-analyser-av-norske-forhold-etter-britisk-studie/ 2025-02-06T11:05:51+00:00 https://www.lmi.no/2025/02/06/26-europeiske-land-har-sagt-ja-til-ny-behandling-av-depresjon-norge-sier-nei/ 2025-02-06T11:06:51+00:00 https://www.lmi.no/2025/02/06/norsk-ketaminstudie-kan-gi-bedre-dokumentasjon/ 2025-02-06T11:08:40+00:00 https://www.lmi.no/2025/02/06/ingen-ny-metodevurdering-for-depresjon-medisin-uten-ny-dokumentasjon/ 2025-02-06T11:12:44+00:00 https://www.lmi.no/2025/02/06/novo-nordisk-vokser-med-25-prosent/ 2025-02-06T11:13:42+00:00 https://www.lmi.no/2025/02/06/norsk-etterretning-personer-tilknyttet-den-kinesiske-arme-har-deltatt-pa-norske-teknologikonferanser-i-2024/ 2025-02-06T11:14:43+00:00 https://www.lmi.no/2025/02/06/flere-pasienter-rammet-kreftstudie-stanset-etter-alvorlige-komplikasjoner/ 2025-02-06T11:15:32+00:00 https://www.lmi.no/2025/02/06/en-hiv-sproyte-skulle-bli-et-vendepunkt-i-2025-men-sa-kom-donald-trump/ 2025-02-06T11:16:22+00:00 https://www.lmi.no/2025/02/06/ny-medisin-pa-topplisten-i-norge-ekspert-advarer/ 2025-02-06T11:17:13+00:00 https://www.lmi.no/2025/02/06/ny-migrene-medisin-kan-naermest-bety-en-ny-tilvaerelse/ 2025-02-06T11:18:09+00:00